10-Q
1http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent1false11--12-31Q261000180369611http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent110001803696xper:OperatingAccountsMember2022-06-300001803696xper:EuropeAndMiddleEastMember2021-01-012021-06-300001803696us-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696srt:MaximumMemberxper:ExistingTechnologyContentDatabaseMember2022-01-012022-06-300001803696srt:MinimumMemberxper:AcquiredPatentsCoreTechnologyMember2022-01-012022-06-300001803696us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696srt:MinimumMemberxper:ExistingTechnologyContentDatabaseMember2022-01-012022-06-300001803696us-gaap:CommonStockMember2021-06-300001803696us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696us-gaap:EmployeeStockMember2022-04-012022-06-300001803696us-gaap:BuildingAndBuildingImprovementsMember2021-12-310001803696us-gaap:TreasuryStockMember2021-03-310001803696xper:AcquiredPatentsCoreTechnologyMember2022-06-300001803696us-gaap:AccountingStandardsUpdate202108Member2022-06-300001803696us-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696us-gaap:RestrictedStockMemberxper:AssumedPlansMember2022-01-012022-06-3000018036962022-01-012021-12-310001803696us-gaap:TradeAccountsReceivableMember2021-12-310001803696us-gaap:BuildingAndBuildingImprovementsMember2022-06-300001803696us-gaap:GeographicConcentrationRiskMembercountry:JPus-gaap:SalesRevenueNetMember2021-01-012021-06-300001803696us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-06-300001803696xper:UnbilledContractsReceivableMember2022-04-012022-06-300001803696us-gaap:TrademarksAndTradeNamesMember2022-06-300001803696us-gaap:NoncontrollingInterestMember2022-03-310001803696us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001803696us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696xper:ProductLicensingSegmentMember2021-01-012021-06-300001803696xper:ProductLicensingSegmentMember2022-01-012022-06-300001803696us-gaap:GeographicConcentrationRiskMemberxper:OtherAsiaMemberus-gaap:SalesRevenueNetMember2021-04-012021-06-300001803696us-gaap:TradeAccountsReceivableMember2022-03-310001803696srt:MinimumMemberus-gaap:PerformanceSharesMember2022-01-012022-06-300001803696us-gaap:EmployeeStockMember2022-01-012022-06-300001803696xper:TiVoTradenameTrademarksMember2021-12-310001803696xper:ProductLicensingSegmentMemberxper:PayTVMember2021-01-012021-06-300001803696xper:TwoThousandTwentyTermBLoanFacilityMember2021-04-012021-06-300001803696xper:RefinancedTermBLoansMember2022-01-012022-06-300001803696us-gaap:CorporateDebtSecuritiesMember2022-06-300001803696us-gaap:TreasuryStockMember2021-01-012021-06-300001803696us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-3000018036962024-07-012022-06-300001803696us-gaap:TrademarksAndTradeNamesMember2021-12-310001803696xper:RefinancedTermBLoanMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696xper:TwoThousandTwentyEquityIncentivePlanMember2022-01-012022-06-300001803696us-gaap:RetainedEarningsMember2020-12-310001803696us-gaap:LandMember2021-12-310001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercountry:US2021-04-012021-06-300001803696us-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-300001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMemberxper:EuropeAndMiddleEastMember2021-04-012021-06-300001803696xper:RestrictedStockAwardsAndUnitsMember2022-06-300001803696us-gaap:AvailableforsaleSecuritiesMember2022-06-300001803696xper:TermBLoanFacilityMember2021-12-310001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercountry:KR2021-04-012021-06-300001803696us-gaap:NoncontrollingInterestMember2022-01-012022-06-300001803696xper:TermBLoanFacilityMember2022-06-300001803696us-gaap:DevelopedTechnologyRightsMemberxper:MobiTVMember2021-05-312021-05-310001803696us-gaap:RetainedEarningsMember2021-04-012021-06-300001803696xper:RefinancedTermBLoansMember2021-06-080001803696xper:CustomerContractsAndRelatedRelationshipsMember2021-12-3100018036962022-04-012022-06-300001803696us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300001803696us-gaap:CommercialPaperMember2022-06-300001803696xper:ProductLicensingSegmentMember2022-06-300001803696us-gaap:EmployeeStockOptionMember2021-04-012021-06-300001803696us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696xper:CostOfRevenueExcludingDepreciationAndAmortizationOfIntangibleAssetsMember2021-04-012021-06-300001803696us-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696us-gaap:TreasuryStockMember2022-06-300001803696xper:RefinancedTermBLoansMemberxper:EurodollarWithLondonInterbankOfferedRateLIBORMember2021-06-082021-06-080001803696srt:MaximumMember2022-01-012022-06-300001803696us-gaap:NoncontrollingInterestMember2021-06-300001803696us-gaap:NoncontrollingInterestMember2021-12-310001803696xper:MobiTVMember2021-04-012021-06-300001803696us-gaap:EmployeeStockMember2021-09-012021-09-3000018036962025-01-012021-12-310001803696xper:PerformanceBasedRestrictedStockAwardAndRestrictedStockUnitsMember2022-06-300001803696country:US2021-04-012021-06-300001803696us-gaap:CommercialPaperMember2021-12-310001803696us-gaap:OperatingSegmentsMemberxper:IntellectualPropertyLicensingSegmentMember2021-01-012021-06-300001803696xper:EuropeAndMiddleEastMember2021-04-012021-06-300001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercountry:KR2021-01-012021-06-300001803696xper:ProductLicensingSegmentMemberxper:MediaPlatformMember2021-04-012021-06-300001803696us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001803696us-gaap:OperatingSegmentsMemberxper:ProductLicensingSegmentMember2021-04-012021-06-300001803696us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696xper:TimeBasedRestrictedStockAwardAndRestrictedStockUnitsMember2021-12-310001803696xper:EquipmentFurnitureAndOtherMember2021-12-310001803696us-gaap:CashAndCashEquivalentsMember2021-12-3100018036962022-03-310001803696us-gaap:AvailableforsaleSecuritiesMember2021-12-310001803696xper:IntellectualPropertyLicensingSegmentMember2022-06-3000018036962023-01-012021-12-310001803696srt:MaximumMemberus-gaap:PerformanceSharesMember2022-01-012022-06-3000018036962027-01-012021-12-310001803696xper:AssumedPlansMember2022-01-012022-06-300001803696us-gaap:SubsequentEventMember2022-07-292022-07-290001803696xper:RefinancedTermBLoansMember2021-01-012021-06-300001803696xper:RestrictedStockAwardsAndUnitsMember2022-04-012022-06-300001803696xper:UnbilledContractsReceivableMember2021-01-012021-06-300001803696xper:ProductLicensingSegmentMemberxper:ConsumerElectronicsMember2021-01-012021-06-300001803696us-gaap:CommonStockMember2022-06-300001803696us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-3000018036962020-06-132022-06-300001803696country:JPus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300001803696us-gaap:TreasuryStockMember2021-12-310001803696us-gaap:RetainedEarningsMember2021-03-310001803696us-gaap:RestrictedStockUnitsRSUMember2021-03-012021-03-310001803696xper:UnbilledContractsReceivableMember2021-03-310001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMemberxper:EuropeAndMiddleEastMember2022-04-012022-06-300001803696xper:RefinancedTermBLoansMember2022-04-012022-06-300001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercountry:KR2022-01-012022-06-300001803696us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696xper:IntellectualPropertyLicensingRevenueMember2022-04-012022-06-300001803696xper:UnbilledContractsReceivableMember2020-12-310001803696us-gaap:AdditionalPaidInCapitalMember2020-12-310001803696us-gaap:TradeAccountsReceivableMember2022-04-012022-06-3000018036962026-01-012021-12-310001803696country:KR2022-04-012022-06-300001803696xper:TimeBasedRestrictedStockAwardAndRestrictedStockUnitsMember2022-01-012022-06-3000018036962023-07-012022-06-300001803696srt:MaximumMember2022-06-300001803696us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696xper:ResearchDevelopmentAndOtherRelatedCostsMember2022-01-012022-06-300001803696xper:ProductLicensingSegmentMemberxper:ConnectedCarMember2021-01-012021-06-300001803696us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001803696us-gaap:EmployeeStockMember2022-06-300001803696xper:ProductLicensingSegmentMemberxper:ConnectedCarMember2022-04-012022-06-300001803696us-gaap:MoneyMarketFundsMember2021-12-310001803696xper:ProductLicensingSegmentMemberxper:PayTVMember2022-04-012022-06-300001803696xper:RefinancedTermBLoansMemberus-gaap:BaseRateMember2021-06-082021-06-080001803696us-gaap:SubsequentEventMemberxper:VewdSoftwareHoldingsLimitedMember2022-07-012022-07-0100018036962021-03-310001803696xper:CostOfRevenueExcludingDepreciationAndAmortizationOfIntangibleAssetsMember2022-01-012022-06-300001803696us-gaap:MaterialReconcilingItemsMember2022-01-012022-06-300001803696us-gaap:CommonStockMember2021-03-310001803696us-gaap:RetainedEarningsMember2021-12-310001803696xper:EuropeAndMiddleEastMember2022-04-012022-06-300001803696us-gaap:TradeAccountsReceivableMember2021-04-012021-06-300001803696xper:RefinancedTermBLoanMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696country:US2021-01-012021-06-300001803696us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696xper:AcquiredPatentsCoreTechnologyMember2021-12-310001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercountry:US2022-04-012022-06-300001803696country:JP2022-01-012022-06-300001803696us-gaap:GeographicConcentrationRiskMemberxper:OtherAsiaMemberus-gaap:SalesRevenueNetMember2021-01-012021-06-300001803696country:KR2022-01-012022-06-3000018036962022-06-300001803696xper:MobiTVMember2021-05-310001803696xper:PerformanceBasedRestrictedStockAwardAndRestrictedStockUnitsMember2021-12-3100018036962021-04-012021-06-300001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300001803696us-gaap:CommonStockMember2021-01-012021-06-300001803696us-gaap:CommonStockMember2022-03-310001803696us-gaap:NoncontrollingInterestMember2022-06-300001803696xper:RefinancedTermBLoansMember2021-12-310001803696srt:MinimumMemberxper:CustomerContractsAndRelatedRelationshipsMember2022-01-012022-06-300001803696xper:ProductLicensingSegmentMemberxper:PayTVMember2021-04-012021-06-300001803696us-gaap:TreasuryStockMember2022-01-012022-06-300001803696us-gaap:CommonStockMember2021-04-012021-06-300001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMemberxper:EuropeAndMiddleEastMember2021-01-012021-06-300001803696us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696us-gaap:TreasuryStockMember2020-12-310001803696xper:ProductLicensingSegmentMemberxper:ConnectedCarMember2022-01-012022-06-300001803696us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696us-gaap:NoncontrollingInterestMember2021-03-3100018036962022-07-250001803696xper:TwoThousandTwentyTermBLoanFacilityMember2020-06-010001803696xper:ExistingTechnologyContentDatabaseMember2022-06-300001803696xper:ProductLicensingSegmentMemberxper:PayTVMember2022-01-012022-06-300001803696xper:SeparationAgreementMember2022-01-012022-03-310001803696us-gaap:DevelopedTechnologyRightsMemberxper:MobiTVMember2021-05-310001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-04-012021-06-300001803696xper:TIVOMergerMemberxper:NonMarketableEquitySecuritiesMember2021-12-310001803696us-gaap:EmployeeStockMember2022-04-292022-04-2900018036962020-06-120001803696us-gaap:LandMember2022-06-300001803696us-gaap:GeographicConcentrationRiskMemberxper:OtherAsiaMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300001803696xper:ProductLicensingSegmentMemberxper:ConnectedCarMember2021-04-012021-06-300001803696xper:IntellectualPropertyLicensingRevenueMember2022-01-012022-06-300001803696us-gaap:GeographicConcentrationRiskMembercountry:JPus-gaap:SalesRevenueNetMember2021-04-012021-06-300001803696us-gaap:NoncontrollingInterestMember2021-04-012021-06-3000018036962025-07-012022-06-300001803696xper:IntellectualPropertyLicensingRevenueMember2021-01-012021-06-300001803696xper:ProductLicensingSegmentMemberxper:ConsumerElectronicsMember2022-01-012022-06-300001803696us-gaap:OperatingSegmentsMemberxper:IntellectualPropertyLicensingSegmentMember2021-04-012021-06-300001803696xper:UnbilledContractsReceivableMember2022-01-012022-06-300001803696xper:TIVOMergerMemberxper:NonMarketableEquitySecuritiesMember2022-06-300001803696us-gaap:EmployeeStockMember2021-04-012021-06-300001803696xper:EuropeAndMiddleEastMember2022-01-012022-06-300001803696us-gaap:MaterialReconcilingItemsMember2022-04-012022-06-300001803696us-gaap:NoncompeteAgreementsMember2022-06-300001803696xper:RestrictedStockAwardsAndUnitsMember2022-01-012022-06-300001803696us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001803696us-gaap:TradeAccountsReceivableMember2020-12-310001803696us-gaap:TreasuryStockMember2021-06-300001803696us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-04-012021-06-300001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercountry:KR2022-04-012022-06-300001803696us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001803696xper:ProductLicensingSegmentMemberxper:MediaPlatformMember2021-01-012021-06-300001803696country:KR2021-01-012021-06-300001803696xper:TimeBasedRestrictedStockAwardAndRestrictedStockUnitsMember2022-06-300001803696country:JP2021-01-012021-06-300001803696us-gaap:LeaseholdImprovementsMember2021-12-310001803696xper:ResearchDevelopmentAndOtherRelatedCostsMember2021-01-012021-06-300001803696us-gaap:LeaseholdImprovementsMember2022-06-300001803696xper:ProductLicensingSegmentMemberxper:MediaPlatformMember2022-01-012022-06-300001803696us-gaap:InventoriesMember2022-06-300001803696srt:MinimumMember2022-06-300001803696us-gaap:AdditionalPaidInCapitalMember2022-01-012022-06-300001803696xper:ExistingTechnologyContentDatabaseMember2021-12-310001803696us-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696us-gaap:GeographicConcentrationRiskMemberxper:OtherAsiaMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300001803696us-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696us-gaap:TradeAccountsReceivableMember2021-06-300001803696xper:RestrictedStockAwardsAndUnitsMember2021-04-012021-06-300001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-01-012021-06-300001803696us-gaap:RetainedEarningsMember2022-01-012022-06-300001803696xper:ResearchDevelopmentAndOtherRelatedCostsMember2021-04-012021-06-300001803696us-gaap:RetainedEarningsMember2022-04-012022-06-300001803696us-gaap:OperatingSegmentsMemberxper:ProductLicensingSegmentMember2022-01-012022-06-300001803696xper:OtherAsiaMember2022-04-012022-06-300001803696xper:UnbilledContractsReceivableMember2022-06-300001803696us-gaap:TreasuryStockMember2022-04-012022-06-300001803696us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001803696us-gaap:TradeAccountsReceivableMember2022-06-300001803696us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696us-gaap:NoncompeteAgreementsMember2021-12-310001803696us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-06-300001803696us-gaap:CommonStockMember2020-12-310001803696xper:OtherAsiaMember2021-01-012021-06-300001803696xper:IntellectualPropertyLicensingRevenueMember2021-04-012021-06-3000018036962020-06-020001803696xper:CostOfRevenueExcludingDepreciationAndAmortizationOfIntangibleAssetsMember2021-01-012021-06-300001803696xper:RefinancedTermBLoansMember2022-06-300001803696us-gaap:AdditionalPaidInCapitalMember2021-06-300001803696xper:ProductLicensingSegmentMemberxper:ConsumerElectronicsMember2021-04-012021-06-300001803696us-gaap:AdditionalPaidInCapitalMember2021-03-310001803696us-gaap:RetainedEarningsMember2022-03-310001803696xper:PerceiveCorporationMember2022-06-300001803696xper:PerformanceBasedRestrictedStockAwardAndRestrictedStockUnitsMember2022-01-012022-06-300001803696us-gaap:OperatingSegmentsMemberxper:ProductLicensingSegmentMember2022-04-012022-06-300001803696us-gaap:TrademarksAndTradeNamesMembersrt:MinimumMember2022-01-012022-06-300001803696xper:MobiTVMember2021-01-012021-06-300001803696us-gaap:TradeAccountsReceivableMember2021-03-310001803696xper:UnbilledContractsReceivableMember2021-06-300001803696us-gaap:PatentsMemberxper:MobiTVMember2021-05-312021-05-310001803696xper:UnbilledContractsReceivableMember2021-12-310001803696us-gaap:TradeAccountsReceivableMember2021-01-012021-06-3000018036962021-01-012021-06-300001803696srt:MaximumMemberxper:AcquiredPatentsCoreTechnologyMember2022-01-012022-06-3000018036962021-04-220001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMemberxper:EuropeAndMiddleEastMember2022-01-012022-06-3000018036962027-07-012022-06-300001803696xper:ResearchDevelopmentAndOtherRelatedCostsMember2022-04-012022-06-300001803696us-gaap:CommonStockMember2021-12-310001803696xper:SeparationAgreementMember2022-03-012022-03-010001803696xper:TwoThousandTwentyEquityIncentivePlanAndAssumedPlansMemberus-gaap:EmployeeStockOptionMember2022-06-300001803696us-gaap:AdditionalPaidInCapitalMember2021-12-310001803696us-gaap:NoncontrollingInterestMember2021-01-012021-06-3000018036962021-06-300001803696xper:CostOfRevenueExcludingDepreciationAndAmortizationOfIntangibleAssetsMember2022-04-012022-06-300001803696us-gaap:CorporateDebtSecuritiesMember2021-12-310001803696us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-3100018036962026-07-012022-06-300001803696xper:TiVoTradenameTrademarksMember2022-06-300001803696xper:UnbilledContractsReceivableMember2021-04-012021-06-300001803696us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696us-gaap:EmployeeStockMember2021-03-012021-03-310001803696xper:TIVOMergerMemberxper:NonMarketableEquitySecuritiesMember2022-01-012022-06-300001803696country:JP2022-04-012022-06-300001803696us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696country:JPus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300001803696us-gaap:EmployeeStockOptionMember2021-01-012021-06-300001803696xper:RefinancedTermBLoansMember2021-06-082021-06-080001803696xper:TIVOMergerMemberxper:NonMarketableEquitySecuritiesMember2021-01-012021-06-300001803696xper:TwoThousandTwentyTermBLoanFacilityMember2020-06-012020-06-010001803696country:JP2021-04-012021-06-300001803696us-gaap:OperatingSegmentsMemberxper:ProductLicensingSegmentMember2021-01-012021-06-300001803696us-gaap:MaterialReconcilingItemsMember2021-01-012021-06-300001803696us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001803696us-gaap:EmployeeStockMember2022-03-012022-03-3100018036962024-01-012021-12-310001803696xper:ProductLicensingSegmentMemberxper:MediaPlatformMember2022-04-012022-06-300001803696us-gaap:MaterialReconcilingItemsMember2021-04-012021-06-300001803696us-gaap:SubsequentEventMemberxper:VewdSoftwareHoldingsLimitedMember2022-07-010001803696us-gaap:PatentsMemberxper:MobiTVMember2021-05-310001803696country:US2022-04-012022-06-300001803696us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-04-012022-06-300001803696us-gaap:NoncompeteAgreementsMember2022-01-012022-06-300001803696us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-3000018036962022-07-012022-06-300001803696us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001803696xper:TwoThousandTwentyEquityIncentivePlanMemberxper:TimeBasedAwardsMember2022-01-012022-06-300001803696us-gaap:AdditionalPaidInCapitalMember2022-03-310001803696us-gaap:RestrictedStockUnitsRSUMember2022-04-012022-04-300001803696us-gaap:OperatingSegmentsMemberxper:IntellectualPropertyLicensingSegmentMember2022-01-012022-06-300001803696xper:RestrictedStockAwardsAndUnitsMember2021-01-012021-06-300001803696us-gaap:TreasuryStockMember2022-03-310001803696us-gaap:TreasuryStockMember2021-04-012021-06-300001803696us-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696xper:ProductLicensingSegmentMemberxper:ConsumerElectronicsMember2022-04-012022-06-300001803696xper:EquipmentFurnitureAndOtherMember2022-06-300001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercountry:US2021-01-012021-06-300001803696us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-300001803696us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercountry:US2022-01-012022-06-300001803696us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001803696us-gaap:NoncontrollingInterestMember2022-04-012022-06-300001803696us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696us-gaap:OperatingSegmentsMemberxper:IntellectualPropertyLicensingSegmentMember2022-04-012022-06-300001803696xper:OtherAsiaMember2021-04-012021-06-300001803696xper:CustomerContractsAndRelatedRelationshipsMember2022-06-300001803696xper:OtherAsiaMember2022-01-012022-06-3000018036962021-12-310001803696us-gaap:MoneyMarketFundsMember2022-06-300001803696country:KR2021-04-012021-06-300001803696us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-3100018036962020-06-012021-12-310001803696us-gaap:NoncontrollingInterestMember2020-12-310001803696us-gaap:AdditionalPaidInCapitalMember2022-06-300001803696us-gaap:RetainedEarningsMember2021-01-012021-06-300001803696us-gaap:RestrictedStockUnitsRSUMember2022-06-012022-06-300001803696us-gaap:RetainedEarningsMember2021-06-300001803696srt:MaximumMemberxper:CustomerContractsAndRelatedRelationshipsMember2022-01-012022-06-300001803696xper:RefinancedTermBLoansMember2021-04-012021-06-300001803696xper:ProductLicensingSegmentMember2022-04-012022-06-300001803696us-gaap:CommonStockMember2022-04-012022-06-300001803696country:US2022-01-012022-06-300001803696us-gaap:CashAndCashEquivalentsMember2022-06-300001803696us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001803696us-gaap:TradeAccountsReceivableMember2022-01-012022-06-300001803696xper:UnbilledContractsReceivableMember2022-03-310001803696us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001803696xper:OperatingAccountsMember2021-12-3100018036962022-01-012022-06-300001803696xper:TwoThousandTwentyTermBLoanFacilityMember2022-06-300001803696us-gaap:EmployeeStockMember2021-01-012021-06-300001803696us-gaap:RetainedEarningsMember2022-06-3000018036962020-12-310001803696xper:ProductLicensingSegmentMember2021-04-012021-06-300001803696xper:TwoThousandTwentyEquityIncentivePlanMember2022-06-300001803696xper:TwoThousandTwentyEquityIncentivePlanMember2022-04-292022-04-290001803696xper:TwoThousandTwentyOneConvertibleNotesMember2022-06-300001803696xper:RestrictedStockAwardsAndUnitsMember2021-12-310001803696us-gaap:TrademarksAndTradeNamesMembersrt:MaximumMember2022-01-012022-06-300001803696us-gaap:CommonStockMember2022-01-012022-06-30iso4217:USDxbrli:sharesxbrli:purexper:Segmentxbrli:sharesxper:RevenueModelxper:Patentiso4217:USDxper:Customer

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-39304

 

XPERI HOLDING CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

 

 

Delaware

 

84-4734590

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

 

3025 Orchard Parkway, San Jose, California

 

95134

(Address of Principal Executive Offices)

 

(Zip Code)

(408) 321-6000

(Registrant’s Telephone Number, Including Area Code)

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Common Stock (par value $0.001 per share)

XPER

Nasdaq Global Select Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

Emerging growth company

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

The number of shares outstanding of the registrant’s common stock as of July 25, 2022 was 104,195,026.

 

 


 

XPERI HOLDING CORPORATION

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2022

TABLE OF CONTENTS

 

 

 

 

Page

 

PART I

 

 

Item 1.

Financial Statements (unaudited)

 

 

 

Condensed Consolidated Statements of Operations – Three and Six Months Ended June 30, 2022 and 2021

 

3

 

Condensed Consolidated Statements of Comprehensive Income (Loss) – Three and Six Months Ended June 30, 2022 and 2021

 

4

 

Condensed Consolidated Balance Sheets – June 30, 2022 and December 31, 2021

 

5

 

Condensed Consolidated Statements of Cash Flows – Six Months Ended June 30, 2022 and 2021

 

6

 

Condensed Consolidated Statements of Equity – Three and Six Months Ended June 30, 2022 and 2021

 

7

 

Notes to Condensed Consolidated Financial Statements

 

9

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

34

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

47

Item 4.

Controls and Procedures

 

47

 

 

 

 

 

PART II

 

 

Item 1.

Legal Proceedings

 

49

Item 1A.

Risk Factors

 

50

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

50

Item 3.

Defaults Upon Senior Securities

 

50

Item 4.

Mine Safety Disclosures

 

50

Item 5.

Other Information

 

50

Item 6.

Exhibits

 

51

 

 

 

 

Signatures

 

 

52

 

2


 

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

XPERI HOLDING CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(unaudited)

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,
2022

 

 

June 30,
2021

 

 

June 30,
2022

 

 

June 30,
2021

 

Revenue:

 

$

234,018

 

 

$

222,272

 

 

 

491,438

 

 

 

443,868

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue, excluding depreciation and amortization of intangible assets

 

 

27,074

 

 

 

26,884

 

 

 

54,771

 

 

 

55,014

 

Research, development and other related costs

 

 

62,145

 

 

 

54,408

 

 

 

121,515

 

 

 

109,603

 

Selling, general and administrative

 

 

72,116

 

 

 

67,668

 

 

 

142,562

 

 

 

135,128

 

Depreciation expense

 

 

5,505

 

 

 

5,514

 

 

 

11,371

 

 

 

11,198

 

Amortization expense

 

 

39,166

 

 

 

52,242

 

 

 

78,485

 

 

 

104,437

 

Litigation expense

 

 

3,161

 

 

 

2,302

 

 

 

4,914

 

 

 

4,835

 

Total operating expenses

 

 

209,167

 

 

 

209,018

 

 

 

413,618

 

 

 

420,215

 

Operating income

 

 

24,851

 

 

 

13,254

 

 

 

77,820

 

 

 

23,653

 

Interest expense

 

 

(9,440

)

 

 

(10,555

)

 

 

(17,868

)

 

 

(21,868

)

Other income, net

 

 

254

 

 

 

564

 

 

 

1,221

 

 

 

1,989

 

Loss on debt extinguishment

 

 

-

 

 

 

(8,012

)

 

 

-

 

 

 

(8,012

)

Income (loss) before taxes

 

 

15,665

 

 

 

(4,749

)

 

 

61,173

 

 

 

(4,238

)

Provision for (benefit from) income taxes

 

 

22,138

 

 

 

(2,876

)

 

 

43,670

 

 

 

(6,891

)

Net income (loss)

 

 

(6,473

)

 

 

(1,873

)

 

$

17,503

 

 

$

2,653

 

Less: net loss attributable to noncontrolling interest

 

 

(848

)

 

 

(755

)

 

 

(1,816

)

 

 

(1,516

)

Net income (loss) attributable to the Company

 

$

(5,625

)

 

$

(1,118

)

 

$

19,319

 

 

$

4,169

 

Income (loss) per share attributable to the Company:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.05

)

 

$

(0.01

)

 

$

0.19

 

 

$

0.04

 

Diluted

 

$

(0.05

)

 

$

(0.01

)

 

$

0.18

 

 

$

0.04

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares used in per share
   calculations-basic

 

 

104,001

 

 

 

104,906

 

 

 

103,841

 

 

 

104,923

 

Weighted average number of shares used in per share
   calculations-diluted

 

 

104,001

 

 

 

104,906

 

 

 

105,362

 

 

 

107,667

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3


 

XPERI HOLDING CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in thousands)

(unaudited)

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,
2022

 

 

June 30,
2021

 

 

June 30,
2022

 

 

June 30,
2021

 

Net income (loss)

 

$

(6,473

)

 

$

(1,873

)

 

$

17,503

 

 

$

2,653

 

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

 

 

 

 

Change in foreign currency translation adjustment

 

 

(2,025

)

 

 

80

 

 

 

(2,918

)

 

 

(965

)

Net unrealized loss on available-for-sale
   debt securities

 

 

143

 

 

 

34

 

 

 

22

 

 

 

-

 

Other comprehensive income (loss), net of tax

 

 

(1,882

)

 

 

114

 

 

 

(2,896

)

 

 

(965

)

Comprehensive income (loss)

 

 

(8,355

)

 

 

(1,759

)

 

 

14,607

 

 

 

1,688

 

Less: comprehensive loss attributable to noncontrolling interest

 

 

(848

)

 

 

(755

)

 

 

(1,816

)

 

 

(1,516

)

Comprehensive income (loss) attributable to the Company

 

$

(7,507

)

 

$

(1,004

)

 

$

16,423

 

 

$

3,204

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4


 

XPERI HOLDING CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except for par value)

(unaudited)

 

 

 

June 30,
2022

 

 

December 31,
2021

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

275,319

 

 

$

201,121

 

Available-for-sale debt securities

 

 

10,495

 

 

 

60,534

 

Accounts receivable, net of allowance for credit losses of $2,740 and $3,102, respectively

 

 

128,979

 

 

 

143,683

 

Unbilled contracts receivable, net

 

 

121,704

 

 

 

77,677

 

Other current assets

 

 

41,258

 

 

 

36,459

 

Total current assets

 

 

577,755

 

 

 

519,474

 

Long-term unbilled contracts receivable

 

 

43,021

 

 

 

4,107

 

Property and equipment, net

 

 

58,096

 

 

 

60,974

 

Operating lease right-of-use assets

 

 

62,149

 

 

 

68,498

 

Intangible assets, net

 

 

739,354

 

 

 

817,916

 

Goodwill

 

 

850,100

 

 

 

851,088

 

Other long-term assets

 

 

150,826

 

 

 

147,965

 

Total assets

 

$

2,481,301

 

 

$

2,470,022

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

14,679

 

 

$

7,811

 

Accrued liabilities

 

 

116,007

 

 

 

110,705

 

Current portion of long-term debt, net

 

 

36,210

 

 

 

36,095

 

Deferred revenue

 

 

44,003

 

 

 

35,136

 

Total current liabilities

 

 

210,899

 

 

 

189,747

 

Deferred revenue, less current portion

 

 

32,153

 

 

 

37,107

 

Long-term deferred tax liabilities

 

 

18,227

 

 

 

19,848

 

Long-term debt, net

 

 

711,259

 

 

 

729,392

 

Noncurrent operating lease liabilities

 

 

48,452

 

 

 

54,658

 

Other long-term liabilities

 

 

104,086

 

 

 

98,842

 

Total liabilities

 

 

1,125,076

 

 

 

1,129,594

 

Commitments and contingencies (Note 15)

 

 

 

 

 

 

Company stockholders’ equity:

 

 

 

 

 

 

Preferred stock: $0.001 par value; (2022: authorized 15,000 shares; 2021: authorized 15,000 shares; and no shares issued and outstanding)

 

 

 

 

 

Common stock: $0.001 par value; (2022: authorized 350,000 shares, issued 115,764 shares, outstanding 104,030 shares; 2021: authorized 350,000 shares, issued 113,460, outstanding 103,260 shares)

 

 

116

 

 

 

113

 

Additional paid-in capital

 

 

1,380,814

 

 

 

1,340,480

 

Treasury stock at cost (2022: 11,734 shares; 2021: 10,200 shares)

 

 

(206,757

)

 

 

(178,022

)

Accumulated other comprehensive loss

 

 

(3,648

)

 

 

(752

)

Retained earnings

 

 

196,715

 

 

 

187,814

 

Total Company stockholders’ equity

 

 

1,367,240

 

 

 

1,349,633

 

Noncontrolling interest

 

 

(11,015

)

 

 

(9,205

)

Total equity

 

 

1,356,225

 

 

 

1,340,428

 

Total liabilities and equity

 

$

2,481,301

 

 

$

2,470,022

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5


 

XPERI HOLDING CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

 

 

 

Six Months Ended

 

 

 

June 30, 2022

 

 

June 30, 2021

 

Cash flows from operating activities:

 

 

 

 

 

 

Net income

 

$

17,503

 

 

$

2,653

 

Adjustments to reconcile net income to net cash from operating activities:

 

 

 

 

 

 

Depreciation of property and equipment

 

 

11,371

 

 

 

11,198

 

Amortization of intangible assets

 

 

78,485

 

 

 

104,437

 

Stock-based compensation expense

 

 

32,284

 

 

 

28,054

 

Deferred income taxes

 

 

(1,641

)

 

 

(1,796

)

Loss on debt extinguishment

 

 

 

 

 

8,012

 

Other

 

 

3,148

 

 

 

8,289

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

14,820

 

 

 

(9,260

)

Unbilled contracts receivable

 

 

(82,767

)

 

 

5,978

 

Other assets

 

 

(1,291

)

 

 

(24,096

)

Accounts payable

 

 

6,868

 

 

 

1,307

 

Accrued and other liabilities

 

 

4,340

 

 

 

(44,096

)

Deferred revenue

 

 

3,913

 

 

 

(7,701

)

Net cash from operating activities

 

 

87,033

 

 

 

82,979

 

Cash flows from investing activities:

 

 

 

 

 

 

Purchases of property and equipment

 

 

(8,870

)

 

 

(4,858

)

Proceeds from sale of property and equipment

 

 

86

 

 

 

19

 

Net cash paid for acquisitions

 

 

 

 

 

(17,400

)

Purchases of intangible assets

 

 

(233

)

 

 

(92

)

Purchases of short-term investments

 

 

(4,490

)

 

 

(45,755

)

Proceeds from sales of investments

 

 

28,254

 

 

 

44,321

 

Proceeds from maturities of investments

 

 

26,053

 

 

 

17,550

 

Net cash from investing activities

 

 

40,800

 

 

 

(6,215

)

Cash flows from financing activities:

 

 

 

 

 

 

Dividends paid

 

 

(10,418

)

 

 

(10,514

)

Repayment of debt

 

 

(20,250

)

 

 

(63,750

)

Proceeds from debt, net of debt discount and issuance costs

 

 

 

 

 

(6,843

)

Proceeds from employee stock purchase program and exercise of stock options

 

 

8,059

 

 

 

7,247

 

Repurchases of common stock

 

 

(28,735

)

 

 

(43,324

)

Net cash from financing activities

 

 

(51,344

)

 

 

(117,184

)

Effect of exchange rate changes on cash and cash equivalents

 

 

(2,291

)

 

 

(808

)

Net increase (decrease) in cash and cash equivalents

 

 

74,198

 

 

 

(41,228

)

Cash and cash equivalents at beginning of period

 

 

201,121

 

 

 

170,188

 

Cash and cash equivalents at end of period

 

$

275,319

 

 

$

128,960

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

Interest paid

 

$

15,590

 

 

$

17,677

 

Income taxes paid, net of refunds

 

$

13,400

 

 

$

14,909

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6


 

XPERI HOLDING CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(in thousands)

(unaudited)

 

 

 

Total Company Stockholders' Equity

 

 

 

 

 

 

 

Three Months Ended June 30, 2022

 

Common Stock

 

 

Additional
Paid-In

 

 

Treasury Stock

 

 

Accumulated
Other
Comprehensive

 

 

Retained

 

 

Noncontrolling

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Shares

 

 

Amount

 

 

Loss

 

 

Earnings

 

 

Interest

 

 

Total Equity

 

Balance at April 1, 2022

 

 

103,921

 

 

$

116

 

 

$

1,365,277

 

 

 

11,726

 

 

$

(206,350

)

 

$

(1,766

)

 

$

207,539

 

 

$

(10,169

)

 

$

1,354,647

 

Issuance of subsidiary shares to noncontrolling interest

 

 

 

 

 

 

 

 

(2

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(5,625

)

 

 

(848

)

 

 

(6,473

)

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,882

)

 

 

 

 

 

 

 

 

(1,882

)

Cash dividends paid on common stock ($0.05 per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(5,199

)

 

 

 

 

 

(5,199

)

Issuance of common stock in connection with exercise of stock options

 

 

4

 

 

 

 

 

 

58

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

58

 

Issuance of restricted stock, net of shares canceled

 

 

129

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repurchases of common stock, shares exchanged

 

 

(24

)

 

 

 

 

 

 

 

 

24

 

 

 

(407

)

 

 

 

 

 

 

 

 

 

 

 

(407

)

Shares exchanged and returned to assumed plans

 

 

 

 

 

 

 

 

 

 

 

(16

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

15,481

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,481

 

Balance at June 30, 2022

 

 

104,030

 

 

$

116

 

 

$

1,380,814

 

 

 

11,734

 

 

$

(206,757

)

 

$

(3,648

)

 

$

196,715

 

 

$

(11,015

)

 

$

1,356,225

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Company Stockholders' Equity

 

 

 

 

 

 

 

Six Months Ended June 30, 2022

 

Common Stock

 

 

Additional
Paid-In

 

 

Treasury Stock

 

 

Accumulated
Other
Comprehensive

 

 

Retained

 

 

Noncontrolling

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Shares

 

 

Amount

 

 

Loss

 

 

Earnings

 

 

Interest

 

 

Total Equity

 

Balance at January 1, 2021

 

 

103,260

 

 

$

113

 

 

$

1,340,480

 

 

 

10,200

 

 

$

(178,022

)

 

$

(752

)

 

$

187,814

 

 

$

(9,205

)

 

$

1,340,428

 

Issuance of subsidiary shares to noncontrolling interest

 

 

 

 

 

 

 

 

(6

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6

 

 

 

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19,319

 

 

 

(1,816

)

 

 

17,503

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,896

)

 

 

 

 

 

 

 

 

(2,896

)

Cash dividends paid on common stock ($0.05 per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(10,418

)

 

 

 

 

 

(10,418

)

Issuance of common stock in connection with exercise of stock options

 

 

5

 

 

 

 

 

 

63

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

63

 

Issuance of common stock in connection with employee stock purchase plan

 

 

739

 

 

 

1

 

 

 

7,993

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,994

 

Issuance of restricted stock, net of shares canceled

 

 

1,738

 

 

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

Repurchases of common stock, shares exchanged

 

 

(683

)

 

 

 

 

 

 

 

 

683

 

 

 

(11,475

)

 

 

 

 

 

 

 

 

 

 

 

(11,475

)

Shares exchanged and returned to assumed plans

 

 

 

 

 

 

 

 

 

 

 

(178

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repurchases of common stock

 

 

(1,029

)

 

 

 

 

 

 

 

 

1,029

 

 

 

(17,260

)

 

 

 

 

 

 

 

 

 

 

 

(17,260

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

32,284

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

32,284

 

Balance at June 30, 2022

 

 

104,030

 

 

$

116

 

 

$

1,380,814

 

 

 

11,734

 

 

$

(206,757

)

 

$

(3,648

)

 

$

196,715

 

 

$

(11,015

)

 

$

1,356,225

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

 

 

 

7


 

XPERI HOLDING CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(in thousands)

(unaudited)

 

 

 

 

Total Company Stockholders' Equity

 

 

 

 

 

 

 

Three Months Ended June 30, 2021

 

Common Stock

 

 

Additional
Paid-In

 

 

Treasury Stock

 

 

Accumulated
Other
Comprehensive

 

 

Retained

 

 

Noncontrolling

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Shares

 

 

Amount

 

 

Income (Loss)

 

 

Earnings

 

 

Interest

 

 

Total Equity

 

Balance at April 1, 2021

 

 

104,875

 

 

$

112

 

 

$

1,288,400

 

 

 

6,825

 

 

$

(109,577

)

 

$

185

 

 

$

264,273

 

 

$

(6,516

)

 

$

1,436,877

 

Issuance of subsidiary shares to noncontrolling interest

 

 

 

 

 

 

 

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1

)

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,118

)

 

 

(755

)

 

 

(1,873

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

114

 

 

 

 

 

 

 

 

 

114

 

Cash dividends paid on common stock ($0.05 per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(5,250

)

 

 

 

 

 

(5,250

)

Issuance of common stock in connection with exercise of stock options

 

 

26

 

 

 

 

 

 

532

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

532

 

Issuance of restricted stock, net of shares canceled

 

 

176

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repurchases of common stock, shares exchanged

 

 

(45

)

 

 

 

 

 

 

 

 

45

 

 

 

(991

)

 

 

 

 

 

 

 

 

 

 

 

(991

)

Repurchases of common stock

 

 

(454

)

 

 

 

 

 

 

 

 

454

 

 

 

(9,974

)

 

 

 

 

 

 

 

 

 

 

 

(9,974

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

14,835

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14,835

 

Balance at June 30, 2021

 

 

104,578

 

 

$

112

 

 

$

1,303,768

 

 

 

7,324

 

 

$

(120,542

)

 

$

299

 

 

$

257,905

 

 

$

(7,272

)

 

$

1,434,270

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Company Stockholders' Equity

 

 

 

 

 

 

 

Six Months Ended June 30, 2021

 

Common Stock

 

 

Additional
Paid-In

 

 

Treasury Stock

 

 

Accumulated
Other
Comprehensive

 

 

Retained

 

 

Noncontrolling

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Shares

 

 

Amount

 

 

Income (Loss)

 

 

Earnings

 

 

Interest

 

 

Total Equity

 

Balance at January 1, 2021

 

 

104,775

 

 

$

110

 

 

$

1,268,471

 

 

 

5,407

 

 

$

(77,218

)

 

$

1,264

 

 

$

264,250

 

 

$

(5,758

)

 

$

1,451,119

 

Issuance of subsidiary shares to noncontrolling interest

 

 

 

 

 

 

 

 

(2

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

 

 

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,169

 

 

 

(1,516

)

 

 

2,653

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(965

)

 

 

 

 

 

 

 

 

(965

)

Cash dividends paid on common stock ($0.10 per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(10,514

)

 

 

 

 

 

(10,514

)

Issuance of common stock in connection with exercise of stock options

 

 

37

 

 

 

 

 

 

760

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

760

 

Issuance of common stock in connection with employee stock purchase plan

 

 

633

 

 

 

1

 

 

 

6,485

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,486

 

Issuance of restricted stock, net of shares canceled

 

 

1,050

 

 

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

Repurchases of common stock, shares exchanged

 

 

(392

)

 

 

 

 

 

 

 

 

392

 

 

 

(8,343

)

 

 

 

 

 

 

 

 

 

 

 

(8,343

)

Repurchases of common stock

 

 

(1,525

)

 

 

 

 

 

 

 

 

1,525

 

 

 

(34,981

)

 

 

 

 

 

 

 

 

 

 

 

(34,981

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

28,054

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

28,054

 

Balance at June 30, 2021

 

 

104,578

 

 

$

112

 

 

$

1,303,768

 

 

 

7,324

 

 

$

(120,542

)

 

$

299

 

 

$

257,905

 

 

$

(7,272

)

 

$

1,434,270

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

8


 

XPERI HOLDING CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

NOTE 1 – THE COMPANY AND BASIS OF PRESENTATION

On December 18, 2019, Xperi Corporation (“Xperi”) entered into an Agreement and Plan of Merger and Reorganization with TiVo Corporation (“TiVo”) to combine in an all-stock merger of equals transaction (the “Mergers”). Immediately following the consummation of the Mergers on June 1, 2020 (the “Merger Date”), Xperi Holding Corporation (the “Company”), a Delaware corporation founded in December 2019 under the name “XRAY-TWOLF HoldCo Corporation,” became the parent company of both Xperi and TiVo. The common stock of Xperi and TiVo were de-registered after completion of the Mergers. On June 2, 2020, Xperi Holding Corporation’s common stock, par value $0.001 per share, commenced trading on the Nasdaq Global Select Market (“Nasdaq”) under the ticker symbol “XPER.”

Xperi Holding Corporation is a leading consumer and entertainment product/solutions licensing company and one of the industry’s largest intellectual property licensing platforms, with a diverse portfolio of media and semiconductor intellectual property and more than 11,000 patents and patent applications worldwide. The Company creates extraordinary experiences at home and on the go for millions of consumers around the world, elevating content and how audiences connect with it in a way that is more intelligent, immersive and personal. Powering smart devices, connected cars, entertainment experiences and more, the Company has created a unified ecosystem that reaches highly engaged consumers, uncovering significant new business opportunities, now and in the future. The Company’s technologies are integrated into billions of consumer devices, media platforms, and semiconductors worldwide, driving increased value for partners, customers and consumers.

The accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting principles (“GAAP”) in the United States (“U.S.”) and the applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information. The amounts as of December 31, 2021 have been derived from the Company’s annual audited financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2021, filed on February 24, 2022 (the “Form 10-K”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with such rules and regulations. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments necessary (consisting of normal recurring adjustments) to state fairly the financial position of the Company and its results of operations and cash flows as of and for the periods presented. These financial statements should be read in conjunction with the annual audited financial statements and notes thereto as of and for the year ended December 31, 2021, included in the Form 10-K.

The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2022 or any future period and the Company makes no representations related thereto.

In the fourth quarter of 2018, the Company funded a new subsidiary, Perceive Corporation (“Perceive”), which was created to focus on delivering edge inference solutions. As of June 30, 2022, the Company’s ownership interest in Perceive was approximately 80%. The operating results of Perceive have been consolidated in the Company’s condensed consolidated financial statements for all periods presented.

The Company is currently planning, subject to any required regulatory approvals, a separation of the Company’s product business and IP licensing business through a tax-efficient transaction, resulting in two independent, publicly traded companies. The Company currently anticipates that such separation will be completed in the fall of 2022.

Reclassification

Certain reclassifications have been made to prior period balances in order to conform to the current period’s presentation.

9


 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

There have been no significant changes in the Company’s significant accounting policies during the six months ended June 30, 2022, as compared to the significant accounting policies described in the Form 10-K.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates and assumptions that require management’s most significant, challenging, and subjective judgment include the estimation of licensees’ quarterly royalties prior to receiving the royalty reports, the determination of stand-alone selling price and the transaction price in an arrangement with multiple performance obligations, the estimation of variable consideration, the assessment of the recoverability of goodwill, the assessment of useful lives and recoverability of other intangible assets and long-lived assets, recognition and measurement of current and deferred income tax assets and liabilities, the assessment of unrecognized tax benefits, and purchase accounting resulting from business combinations, among others. Actual results experienced by the Company may differ from management’s estimates. These estimates may change, as new events occur and additional information is obtained, and are recognized in the consolidated financial statements as soon as they become known.

The COVID-19 pandemic has had, and may continue to have, an adverse impact on the Company business. The impact to date has included periods of significant volatility in markets the Company serves, in particular the automotive and broad consumer electronics markets. Additionally, the pandemic has caused some challenges and delays in acquiring new customers and executing license renewals. These factors have negatively impacted the Company's financial condition and results of operations, and may result in an impairment of the Company's long-lived assets, including goodwill, increased credit losses and impairments of investments in other companies. The Company's operations and those of its customers have also been negatively impacted by certain trends arising from the COVID-19 pandemic, including labor market constraints, shortage of semiconductor components and manufacturing capacities, and delays in shipments, product development and product launches. Moreover, the COVID-19 pandemic, its related impact, and United States federal, state and foreign government policies enacted to combat the pandemic have contributed to a recent rise of inflation that may increase the cost of the Company's operations and reduce demand for the Company's products and services and those of its customers, which may adversely affect the Company's financial performance. The impact of the pandemic on the Company's overall results of operations remains uncertain for the foreseeable future and will depend on factors outside the Company's control.

 

Recently Adopted Accounting Pronouncements

In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU 2021-08, “Accounting for Contract Assets and Contract Liabilities from Contracts with Customers” (“ASU 2021-08”), which amends the guidance in ASC 805 to require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Revenue from Contracts with Customers (“Topic 606”). As a result of the amendments, it is expected that an acquirer will generally recognize and measure acquired contract assets and contract liabilities in a manner consistent with how the acquiree recognized and measured them in its preacquisition financial statements. ASU 2021-08 is effective for public business entities for fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company elected to early adopt the new standard on January 1, 2022. The adoption did not have an impact on the Company’s condensed consolidated financial statements.

Recent Accounting Pronouncements

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). ASU 2020-04 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in ASU 2020-04 apply only to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848), which provides further clarification on the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. ASU 2020-04 became effective upon issuance and may be applied prospectively to contract modifications made on or before December 31, 2022. ASU 2021-01 became effective upon issuance and may be applied on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 or prospectively for contract modifications made on or before December 31, 2022.

The Company currently has debt agreements that reference LIBOR and will apply the amendments prospectively through December 31, 2022 as these contracts are modified to reference other rates.

10


 

NOTE 3 – REVENUE

Revenue Recognition

General

Revenue is recognized when control of the promised goods or services is transferred to a customer in an amount that reflects the consideration the Company expects to receive in exchange for those goods or services, which may include various combinations of goods and services which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of sales taxes collected from customers which are subsequently remitted to governmental authorities. In situations where foreign withholding taxes are withheld by the Company’s licensee, revenue is recognized gross of withholding taxes that are remitted directly by the licensee to a local tax authority.

 

Some of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the individual performance obligations are separately accounted for if they are distinct. In an arrangement with multiple performance obligations, the transaction price is allocated among the separate performance obligations on a relative stand-alone selling price basis. The determination of stand-alone selling price considers market conditions, the size and scope of the contract, customer and geographic information, and other factors. When observable prices are not available, stand-alone selling price for separate performance obligations is based on the cost-plus-margin approach, considering overall pricing objectives. The allocation of transaction price among performance obligations in a contract may impact the amount and timing of revenue recognized in the Condensed Consolidated Statements of Operations during a given period.

 

When a contract with a customer includes a variable transaction price, an estimate of the consideration which the Company expects to be entitled to for transferring the promised goods or services is made at contract inception. The amount of variable consideration is estimated at contract inception by considering all available information (historical, current and forecast) at the time and updated as additional information becomes available. The estimate of variable consideration is included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Subsequent changes in the transaction price resulting from changes in the estimate of variable consideration are allocated to the performance obligations in the contract on the same basis as at contract inception.

 

When variable consideration is in the form of a sales-based or usage-based royalty in exchange for a license of IP, or when a license of IP is the predominant item to which the variable consideration relates, revenue is recognized at the later of when the subsequent sale or usage occurs or the performance obligation to which some or all of the sales-based or usage-based royalty has been allocated has been satisfied or partially satisfied.

Description of Revenue-Generating Activities

The Company operates in two business segments. In its IP Licensing segment, the Company licenses its innovations to leading companies in the broader entertainment and semiconductor industries, and those developing new technologies that will help drive the industries forward. Licensing arrangements include access to one or more of the Company’s foundational patent portfolios and may also include access to some of its industry-leading technologies and proven know-how. In its Product segment, the Company derives the majority of its revenue from licensing its technology to customers primarily through Technology License arrangements and Technology Solutions arrangements. For Technology License arrangements, the customer obtains rights to the technology delivered at the commencement of the agreement. For Technology Solutions arrangements, the customer receives access to a platform, media or data that includes frequent updates, where access to such updates is critical to the functionality of the technology.

IP License Arrangements

In its IP Licensing segment, the Company licenses (i) its media patent portfolio (“Media IP licensing”) to multichannel video programming distributors, over-the-top video service providers, consumer electronics manufacturers, social media, and other new media companies and (ii) its semiconductor technologies and associated patent portfolio (“Semiconductor IP licensing”) to memory, sensor, radio frequency component, and foundry companies. The Company licenses its IP portfolios under three revenue models: (i) fixed-fee Media IP licensing, (ii) fixed-fee or minimum guarantee Semiconductor IP licensing, and (iii) per-unit or per-subscriber IP royalty licenses.

 

11


 

Fixed-fee Media IP licensing

The Company's fixed-fee Media IP licensing agreements, which are related to the TiVo businesses following the Mergers, provide its customers with rights to future patented technologies over the term of the agreement that are highly interdependent or highly interrelated to the patented technologies provided at the inception of the agreement. The Company treats these rights as a single performance obligation with revenue recognized on a straight-line basis over the term of the fixed-fee license agreement.

At times, the Company enters into license agreements in which a licensee is released from past patent infringement claims or is granted a license to ship an unlimited number of units or for an unlimited number of subscribers over a future period for a fixed fee. In these arrangements, the Company allocates the transaction price between the release for past patent infringement claims and the future license which requires significant management judgment. In determining the stand-alone selling price of the release for past patent infringement claims and the future license, the Company considers such factors as the number of units shipped in the past or the number of past subscribers and the relevant geographies of the shipped units or subscribers, the future number of subscribers or units, as well as the licensing rate the Company generally receives for per-subscriber or units shipped in the same geographies. As the release from past patent infringement claims is generally satisfied at execution of the agreement, the transaction price allocated to the release from past patent infringement claims is generally recognized in the period the agreement is executed and the amount of transaction price allocated to the future license is recognized ratably over the future license term.

Fixed-fee or minimum guarantee Semiconductor IP licensing

The Company enters into Semiconductor IP licenses that have fixed fee or minimum guarantee arrangements, whereby licensees pay a fixed fee for the right to incorporate the Company’s IP technologies in the licensee’s products over the license term. In arrangements with a minimum guarantee, the fixed fee component corresponds to a minimum number of units or dollars that the customer must produce or pay, with additional per-unit fees for any units or dollars exceeding the minimum. The Company generally recognizes the full fixed fee as revenue at the beginning of the license term when the customer has the right to use the IP and begins to benefit from the license, net of the effect of any significant financing components calculated using customer-specific, risk-adjusted lending rates, with the related interest income being recognized over time on an effective rate basis. For minimum guarantee agreements where the customer exceeds the minimum, the Company recognizes revenue relating to any additional per-unit fees in the periods it believes the customer will exceed the minimum and adjusts the revenue based on actual usage once that is reported by the customer.

Per-unit or per-subscriber IP royalty licenses

The Company recognizes revenue from per-unit or per-subscriber IP royalty licenses in the period in which the licensee's sales or production are estimated to have occurred, which results in an adjustment to revenue when actual sales or production are subsequently reported by the licensee, which is generally in the month or quarter following usage or shipment. Estimating customers’ monthly or quarterly royalties prior to receiving the royalty reports requires the Company to make significant assumptions and judgments related to forecasted trends and growth rates used to estimate quantities shipped or manufactured by customers, which could have a material impact on the amount of revenue it reports on a quarterly basis.

Technology License Arrangements

The Company licenses its audio, digital radio and imaging technology to consumer electronics (“CE”) manufacturers, automotive manufacturers or their supply chain partners.

The Company generally recognizes royalty revenue from licenses based on units shipped or manufactured. Revenue is recognized in the period in which the customer’s sales or production are estimated to have occurred. This may result in an adjustment to revenue when actual sales or production are subsequently reported by the customer, generally in the month or quarter following sales or production. Estimating customers’ quarterly royalties prior to receiving the royalty reports requires the Company to make significant assumptions and judgments related to forecasted trends and growth rates used to estimate quantities shipped or manufactured by customers, which could have a material impact on the amount of revenue it reports on a quarterly basis.

12


 

Certain customers enter into fixed fee or minimum guarantee agreements, whereby customers pay a fixed fee for the right to incorporate the Company’s technology in the customer’s products over the license term. In arrangements with a minimum guarantee, the fixed fee component corresponds to a minimum number of units or dollars that the customer must produce or pay, with additional per-unit fees for any units or dollars exceeding the minimum. The Company generally recognizes the full fixed fee as revenue at the beginning of the license term when the customer has the right to use the technology and begins to benefit from the license, net of the effect of any significant financing components calculated using customer-specific, risk-adjusted lending rates, with the related interest income being recognized over time on an effective rate basis. For minimum guarantee agreements where the customer exceeds the minimum, the Company recognizes revenue relating to any additional per-unit fees in the periods it believes the customer will exceed the minimum and adjusts the revenue based on actual usage once that is reported by the customer.

Technology Solutions Arrangements

Technology Solutions customers are primarily multi-channel video service providers, CE manufacturers, and end consumers. Technology Solutions revenue is primarily derived from licensing the Company’s Pay-TV solutions, Personalized Content Discovery, enriched Metadata, and viewership data; selling TiVo-enabled devices like the Stream 4K; and advertising.

For Technology Solutions, the Company provides on-going media or data delivery, hosting and access to its platform, and software updates. For these solutions, the Company generally receives fees on a per-subscriber per-month basis or as a fixed fee, and revenue is recognized during the month in which the solutions are provided to the customer. For most of the Technology Solutions offerings, substantially all functionality is obtained through the Company’s continuous hosting and/or updating of the data and content. In these instances, the Company typically has a single performance obligation related to these ongoing activities in the underlying arrangement. For those arrangements that include multiple performance obligations, the Company allocates the consideration as described above and recognizes revenue for each distinct performance obligation when control of the promised goods or services is transferred to the customer.

The Company also generates revenue from non-recurring engineering (“NRE”) services, advertising, and hardware products, each of which was less than 5% of total revenue for all periods presented.

Practical Expedients and Exemptions

The Company applies a practical expedient to not perform an evaluation of whether a contract includes a significant financing component when the timing of revenue recognition differs from the timing of cash collection by one year or less.

The Company applies a practical expedient to expense costs to obtain a contract with a customer as incurred as a component of selling, general and administrative expenses when the amortization period would have been one year or less.

The Company applies a practical expedient when disclosing revenue expected to be recognized from unsatisfied performance obligations to exclude contracts with customers with an original duration of less than one year; amounts attributable to variable consideration arising from (i) a sales-based or usage-based royalty of an intellectual property license or (ii) when variable consideration is allocated entirely to a wholly unsatisfied performance obligation; or to a wholly unsatisfied promise to transfer a distinct good or service that forms part of a single performance obligation.

Revenue Details

The following information depicts how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors by disaggregating revenue by product category/end market and geographic location (presented in “Note 16 - Segment and Geographic Information”).

13


 

Revenue disaggregated by product category/end market was as follows (in thousands):

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

IP Licensing revenue

 

$

107,815

 

 

$

101,846

 

 

$

246,347

 

 

$

199,860

 

Pay-TV

 

 

60,371

 

 

 

67,161

 

 

 

124,525

 

 

 

130,904

 

Consumer Electronics

 

 

39,493

 

 

 

22,715

 

 

 

67,583

 

 

 

53,820

 

Connected Car

 

 

20,855

 

 

 

22,529

 

 

 

40,574

 

 

 

45,420

 

Media Platform

 

 

5,484

 

 

 

8,021

 

 

 

12,409

 

 

 

13,864

 

Total Product revenue

 

 

126,203

 

 

 

120,426

 

 

 

245,091

 

 

 

244,008

 

Total revenue

 

$

234,018

 

 

$

222,272

 

 

$

491,438

 

 

$

443,868

 

 

Contract Balances

Contracts Assets

Contract assets primarily consist of unbilled contracts receivable that are expected to be received from customers in future periods, where the revenue recognized to date exceeds the amount billed. The amount of unbilled contracts receivable may not exceed their net realizable value and are classified as long-term assets if the payments are expected to be received more than one year from the reporting date. Contract assets also include the incremental costs of obtaining a contract with a customer, principally sales commissions when the renewal commission is not commensurate with the initial commission, and deferred engineering costs for significant software customization or modification and set-up services to the extent deemed recoverable.

Contract assets were recorded in the Condensed Consolidated Balance Sheets as follows (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Unbilled contracts receivable (1)

 

$

121,704

 

 

$

77,677

 

Other current assets

 

 

1,128

 

 

 

1,150

 

Long-term unbilled contracts receivable (2)

 

 

43,021

 

 

 

4,107

 

Other long-term assets

 

 

2,196

 

 

 

2,310

 

Total contract assets

 

$

168,049

 

 

$

85,244

 

(1)
The unbilled contracts receivable increase relates primarily to a change in billing process and to the recognition of revenue from long-term contracts with two customers in the six months ended June 30,2022. The change in billing process has no impact on the Company’s cash flows.
(2)
The long-term unbilled contracts receivable increase relates primarily to the recognition of revenue from a multi-year contract with one customer in the six months ended June 30, 2022.

 

Contract Liabilities

Contract liabilities are mainly comprised of deferred revenue related to technology solutions arrangements, multi-period licensing, and other offerings for which the Company is paid in advance while the promised good or service is transferred to the customer at a future date or over time. Deferred revenue also includes amounts received related to professional services to be performed in the future. Deferred revenue arises when cash payments are received, including amounts which are refundable, in advance of performance obligations being completed.

Allowance for Credit Losses

The allowance for credit losses, which includes the allowance for accounts receivable and unbilled contracts receivable, represents the Company’s best estimate of lifetime expected credit losses inherent in those financial assets. The Company’s lifetime expected credit losses are determined using relevant information about past events (including historical experience), current conditions, and reasonable and supportable forecasts that affect collectability. The Company monitors its credit exposure through ongoing credit evaluations of its customers’ financial condition and limits the amount of credit extended when deemed necessary. In addition, the Company performs routine credit management activities such as timely account reconciliations, dispute resolution, and payment confirmations. The Company may employ collection agencies and legal counsel to pursue recovery of defaulted receivables.

14


 

The Company’s long-term unbilled contracts receivable is derived from fixed-fee or minimum-guarantee arrangements, primarily with large well-capitalized companies. It is generally considered to be of high credit quality due to past collection history and the nature of the customers.

The following table presents the activity in the allowance for credit losses for the three and six months ended June 30, 2022 and 2021 (in thousands):

 

 

 

Three Months Ended
June 30, 2022

 

 

Six Months Ended
June 30, 2022

 

 

 

Accounts
Receivable

 

 

Unbilled Contracts
Receivable

 

 

Accounts
Receivable

 

 

 

Unbilled Contracts
Receivable

 

Beginning balance

 

$

2,895

 

 

$

542

 

 

$

3,102

 

 

 

$

729

 

Provision for (reversal of) credit losses

 

 

201

 

 

 

(62

)

 

 

21

 

 

 

 

(173

)

Recoveries

 

 

(100

)

 

 

 

 

 

(138

)

 

 

 

-

 

Charged-off/other adjustments

 

 

(256

)

 

 

 

 

 

(245

)

 

 

 

(76

)

Balance at end of period

 

$

2,740

 

 

$

480

 

 

$

2,740

 

 

 

$

480

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
June 30, 2021

 

 

Six Months Ended
June 30, 2021

 

 

 

Accounts
Receivable

 

 

Unbilled Contracts
Receivable

 

 

Accounts
Receivable

 

 

 

Unbilled Contracts
Receivable

 

Beginning balance

 

$

4,038

 

 

$

2,884

 

 

$

7,336

 

 

 

$

2,231

 

Provision for (reversal of) credit losses

 

 

93

 

 

 

390

 

 

 

1,236

 

 

 

 

513

 

Charged-off/other adjustments

 

 

 

 

 

 

 

 

(4,441

)

 

(1

)

 

530

 

Balance at end of period

 

$

4,131

 

 

$

3,274

 

 

$

4,131

 

 

 

$

3,274

 

 

(1) The charge off of accounts receivable during the six months ended June 30, 2021 was primarily related to a customer whose account had been substantially reserved for credit losses in 2020 due to deteriorating financial condition and delinquent payment history.

Additional Disclosures

The following table presents additional revenue and contract disclosures (in thousands):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Revenue recognized in the period from:

 

 

 

 

 

 

 

 

 

 

 

 

Amounts included in deferred revenue at the
    beginning of the period

 

$

7,625

 

 

$

6,936

 

 

$

17,866

 

 

$

18,152

 

Performance obligations satisfied in previous
   periods (true ups, licensee reporting
   adjustments and settlements) (1)

 

$

26,350

 

(2)

$

13,053

 

 

$

26,503

 

(2)

$

32,916

 

 

(1) True ups represent the differences between the Company’s quarterly estimates of per-unit royalty revenue and actual production/sales-based royalties reported by licensees in the following period. Licensee reporting adjustments represent corrections or revisions to previously reported per-unit royalties by licensees, generally resulting from the Company’s inquiries or compliance audits. Settlements represent resolutions of litigation during the period for past royalties owed pursuant to expired or terminated IP license agreements.

 

(2) Includes past royalty revenue from the settlement of a contract dispute with a large mobile imaging customer, and the execution of a long-term license agreement with a leading consumer electronics and OTT service provider. The long-term license agreement is effective as of the expiration of the prior agreement. The Company recorded revenue from both the settlement and the license agreement, referred to above, in the second quarter of 2022 and expects to record revenue from both the settlement and the license agreement in future periods.

15


 

Remaining revenue under contracts with performance obligations represents the aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) under certain of the Company’s fixed fee arrangements and engineering services contracts. The Company's remaining revenue under contracts with performance obligations was as follows (in thousands):

 

 

 

As of

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Revenue from contracts with performance obligations expected to be satisfied in:

 

 

 

 

 

 

2022 (remaining 6 months)

 

$

93,287

 

 

$

176,646

 

2023

 

$

179,882

 

 

 

153,746

 

2024

 

$

146,202

 

 

 

122,488

 

2025

 

$

130,688

 

 

 

110,703

 

2026

 

$

29,068

 

 

 

10,735

 

Thereafter

 

$

60,315

 

 

 

4,441

 

Total

 

$

639,442

 

 

$

578,759

 

 

NOTE 4 – COMPOSITION OF CERTAIN FINANCIAL STATEMENT CAPTIONS

Other current assets consisted of the following (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Prepaid income taxes

 

$

6,463

 

 

$

6,103

 

Prepaid expenses

 

$

20,358

 

 

 

18,616

 

Inventory*

 

$

7,600

 

 

 

5,101

 

Other

 

 

6,837

 

 

 

6,639

 

 

 

$

41,258

 

 

$

36,459

 

*All inventory is finished goods.

 

 

16


 

Property and equipment, net, consisted of the following (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Equipment, furniture and other

 

$

86,241

 

 

$

81,076

 

Building and improvements

 

 

18,331

 

 

 

18,331

 

Land

 

 

5,300

 

 

 

5,300

 

Leasehold improvements

 

 

26,471

 

 

 

25,535

 

 

 

 

136,343

 

 

 

130,242

 

Less: accumulated depreciation and amortization

 

 

(78,247

)

 

 

(69,268

)

 

 

$

58,096

 

 

$

60,974

 

Other long-term assets consisted of the following (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Long-term deferred tax assets

 

$

3,778

 

 

$

3,758

 

Non-current income tax receivable

 

 

114,350

 

 

 

118,085

 

Other assets

 

 

32,698

 

 

 

26,122

 

 

 

$

150,826

 

 

$

147,965

 

Accrued liabilities consisted of the following (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Employee compensation and benefits

 

$

31,486

 

 

$

42,075

 

Third-party royalties

 

 

4,844

 

 

 

4,428

 

Accrued legal fees

 

 

5,451

 

 

 

7,190

 

Accrued expenses

 

 

27,270

 

 

 

30,899

 

Accrued severance

 

 

1,872

 

 

 

1,921

 

Current portion of operating lease liabilities

 

 

16,319

 

 

 

16,467

 

Accrued income taxes

 

 

24,658

 

 

 

2,791

 

Other

 

 

4,107

 

 

 

4,934

 

 

 

$

116,007

 

 

$

110,705

 

Other long-term liabilities consisted of the following (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Long-term income tax payable

 

$

98,487

 

 

$

91,614

 

Other

 

 

5,599

 

 

 

7,228

 

 

 

$

104,086

 

 

$

98,842

 

Accumulated other comprehensive loss consisted of the following (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Unrealized loss on available-for-sale debt securities, net of tax

 

$

(100

)

 

$

(122

)

Foreign currency translation adjustment, net of tax

 

 

(3,548

)

 

 

(630

)

 

 

$

(3,648

)

 

$

(752

)

 

17


 

 

NOTE 5 – FINANCIAL INSTRUMENTS

The Company has investments in debt securities which include corporate bonds and notes, treasury and agency notes and bills, commercial paper, certificates of deposit, and in equity securities consisting of money market funds. The Company classifies its debt securities as available-for-sale (“AFS”), which are accounted for at fair value with credit related losses recognized as a provision for credit loss expense in its Condensed Consolidated Statements of Operations and all non-credit related unrealized gains and losses recognized in accumulated other comprehensive income or loss on the Condensed Consolidated Balance Sheets. Under ASU 2016-01 (Topic 321), equity securities are measured at fair value with unrealized gains and losses recognized in other income and expense, net, on the Condensed Consolidated Statements of Operations.

 

The following is a summary of marketable securities at June 30, 2022 and December 31, 2021 (in thousands):

 

 

 

June 30, 2022

 

 

 

Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Allowance for Credit Losses

 

 

Estimated
Fair
Values

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds and notes

 

$

5,339

 

 

$

 

 

$

(18

)

 

$

 

 

$

5,321

 

Commercial paper

 

 

23,385

 

 

 

 

 

 

(32

)

 

 

 

 

 

23,353

 

Total debt securities

 

 

28,724

 

 

 

 

 

 

(50

)

 

 

 

 

 

28,674

 

Money market funds

 

$

3,949

 

 

 

 

 

 

 

 

 

 

 

 

3,949

 

Total equity securities

 

 

3,949

 

 

 

 

 

 

 

 

 

 

 

 

3,949

 

Total marketable securities

 

$

32,673

 

 

$

 

 

$

(50

)

 

$

 

 

$

32,623

 

Reported in:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

$

22,128

 

Available-for-sale debt securities

 

 

 

 

 

 

 

 

 

 

 

 

 

$

10,495

 

Total marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

$

32,623

 

 

 

 

December 31, 2021

 

 

 

Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Allowance for Credit losses

 

 

Estimated
Fair
Values

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds and notes

 

$

40,466

 

 

$

 

 

$

(53

)

 

$

 

 

$

40,413

 

Commercial paper

 

 

49,609

 

 

 

 

 

 

(18

)

 

 

 

 

 

49,591

 

Total debt securities

 

 

90,075

 

 

 

 

 

 

(71

)

 

 

 

 

 

90,004

 

Money market funds

 

 

12,372

 

 

 

 

 

 

 

 

 

 

 

 

12,372

 

Total equity securities

 

 

12,372

 

 

 

 

 

 

 

 

 

 

 

 

12,372

 

Total marketable securities

 

$

102,447

 

 

$

 

 

$

(71

)

 

$

 

 

$

102,376

 

Reported in:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

$

41,842

 

Available-for-sale debt securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

60,534

 

Total marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

$

102,376

 

At June 30, 2022 and December 31, 2021, the Company had $285.8 million and $261.7 million, respectively, in cash, cash equivalents and short-term investments. A significant portion of these amounts was held in marketable securities, as shown above. The remaining balance of $253.2 million and $159.3 million at June 30, 2022 and December 31, 2021, respectively, was cash held in operating accounts not included in the tables above.

18


 

Debt Securities

The gross realized gains and losses on sales of marketable debt securities were not material during the three and six months ended June 30, 2022 and 2021, respectively.

Unrealized losses on AFS debt securities were $0.1 million and $0.1 million, net of tax, as of June 30, 2022 and December 31, 2021, respectively. The Company evaluated whether the decline in fair value has resulted from credit losses or other factors and concluded these amounts were related to temporary fluctuations in value of AFS securities and were due primarily to changes in interest rates and market conditions of the underlying securities. In addition, the contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost bases of the investments. The Company does not intend to sell the debt securities and it is more-likely-than-not that it will not be required to sell the investments before recovery of their amortized cost bases. The Company did not recognize a provision for credit losses related to its AFS debt securities for the three and six months ended June 30, 2022 and 2021, respectively.

The following table summarizes the fair value and gross unrealized losses related to individual AFS debt securities at June 30, 2022 and December 31, 2021, which have been in a continuous unrealized loss position, aggregated by investment category and length of time (in thousands):

 

 

 

Less Than 12 Months

 

 

12 Months or More

 

 

Total

 

 

Fair Value

 

June 30, 2022

 

Fair Value

 

 

Gross
Unrealized
Losses

 

 

Fair Value

 

 

Gross
Unrealized
Losses

 

 

Fair Value

 

 

Gross
Unrealized
Losses

 

 

Cash and Cash Equivalents

 

 

AFS Debt Securities

 

Corporate bonds and notes

 

$

 

 

$

 

 

$

5,321

 

 

$

(18

)

 

$

5,321

 

 

$

(18

)

 

$

 

 

$

5,321

 

Commercial paper

 

 

23,353

 

 

 

(32

)

 

 

 

 

 

 

 

 

23,353

 

 

 

(32

)

 

 

18,179

 

 

 

5,174

 

Total

 

$

23,353

 

 

$

(32

)

 

$

5,321

 

 

$

(18

)

 

$

28,674

 

 

$

(50

)

 

$

18,179

 

 

$

10,495

 

 

 

 

 

Less Than 12 Months

 

 

12 Months or More

 

 

Total

 

 

Fair Value

 

December 31, 2021

 

Fair Value

 

 

Gross
Unrealized
Losses

 

 

Fair Value

 

 

Gross
Unrealized
Losses

 

 

Fair Value

 

 

Gross
Unrealized
Losses

 

 

Cash and Cash Equivalents

 

 

AFS Debt Securities

 

Corporate bonds and notes

 

$

29,807

 

 

$

(45

)

 

$

10,382

 

 

$

(8

)

 

$

40,189

 

 

$

(53

)

 

$

 

 

$

40,189

 

Commercial paper

 

 

48,091

 

 

 

(18

)

 

 

 

 

 

 

 

 

48,091

 

 

 

(18

)

 

 

29,470

 

 

 

18,621

 

Total

 

$

77,898

 

 

$

(63

)

 

$

10,382

 

 

$

(8

)

 

$

88,280

 

 

$

(71

)

 

$

29,470

 

 

$

58,810

 

 

The estimated fair value of marketable debt securities by contractual maturity at June 30, 2022 is shown below (in thousands). Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations without penalties.

 

 

 

Estimated
Fair Value

 

Due in one year or less

 

$

28,674

 

Due in one to two years

 

 

-

 

Total

 

$

28,674

 

Non-marketable Equity Securities

As of June 30, 2022 and December 31, 2021, other long-term assets included equity securities accounted for under the equity method with a carrying amount of $4.4 million and $4.8 million, respectively, and equity securities without a readily determinable fair value with a carrying amount of $0.1 million and $0.1 million, respectively. No impairments or adjustments to the carrying amount of the Company's equity securities without a readily determinable fair value were recognized in the three and six months ended June 30, 2022 and 2021, respectively.

19


 

NOTE 6 – FAIR VALUE

The Company follows the authoritative guidance for fair value measurement and the fair value option for financial assets and financial liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The established fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:

 

Level 1

Quoted prices in active markets for identical assets.

 

 

Level 2

Observable market-based inputs or unobservable inputs that are corroborated by market data.

 

 

Level 3

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.

 

When applying fair value principles in the valuation of assets, the Company is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The Company calculates the fair value of its Level 1 and Level 2 instruments based on the exchange traded price of similar or identical instruments, where available, or based on other observable inputs. There were no significant transfers into or out of Level 1 or Level 2 that occurred between December 31, 2021 and June 30, 2022. The following sets forth the fair value, and classification within the hierarchy, of the Company’s assets required to be measured at fair value on a recurring basis as of June 30, 2022 (in thousands):

 

 

 

Fair Value

 

 

Quoted
Prices in
Active Markets
for Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds - equity securities (1)

 

$

3,949

 

 

$

3,949

 

 

$

 

 

$

 

Corporate bonds and notes - debt securities (2)

 

 

5,321

 

 

 

 

 

 

5,321

 

 

 

 

Commercial paper - debt securities (3)

 

 

23,353

 

 

 

 

 

 

23,353

 

 

 

 

Total Assets

 

$

32,623

 

 

$

3,949

 

 

$

28,674

 

 

$

 

 

(1)
Reported as cash and cash equivalents in the Condensed Consolidated Balance Sheet.
(2)
Reported as AFS debt securities in the Condensed Consolidated Balance Sheet.
(3)
Reported as cash and cash equivalents if purchased with an original maturity of three months or less at the date of purchase; otherwise reported as AFS debt securities in the Condensed Consolidated Balance Sheet.

The following sets forth the fair value, and classification within the hierarchy, of the Company’s assets required to be measured at fair value on a recurring basis as of December 31, 2021 (in thousands):

 

 

 

Fair Value

 

 

Quoted
Prices in
Active Markets
for Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds - equity securities (1)

 

$

12,372

 

 

$

10,372

 

 

$

2,000

 

 

$

 

Corporate bonds and notes - debt securities (2)

 

 

40,413

 

 

 

 

 

 

40,413

 

 

 

 

Commercial paper - debt securities (3)

 

 

49,591

 

 

 

 

 

 

49,591

 

 

 

 

Total Assets

 

$

102,376

 

 

$

10,372

 

 

$

92,004

 

 

$

 

 

(1)
Reported as cash and cash equivalents in the Condensed Consolidated Balance Sheet.
(2)
Reported as AFS debt securities in the Condensed Consolidated Balance Sheet.
(3)
Reported as cash and cash equivalents if purchased with an original maturity of three months or less at the date of purchase; otherwise reported as AFS debt securities in the Condensed Consolidated Balance Sheet.

20


 

Financial Instruments Not Recorded at Fair Value

The Company’s long-term debt is carried at amortized cost and is measured at fair value on a quarterly basis for disclosure purposes. The carrying amounts and estimated fair values are as follows (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

 

 

Carrying
Amount

 

 

Estimated
Fair Value

 

 

Carrying
Amount

 

 

Estimated
Fair Value

 

Refinanced Term B Loans (1)

 

$

747,469

 

 

$

710,096

 

 

$

765,487

 

 

$

764,530

 

(1)
Carrying amounts of long-term debt are net of unamortized debt discount and issuance costs of $22.0 million and $24.3 million as of June 30, 2022 and December 31, 2021, respectively. See “Note 9 – Debt” for additional information.

If reported at fair value in the Condensed Consolidated Balance Sheets, the Company’s debt would be classified within Level 2 of the fair value hierarchy. The fair value of the debt was estimated based on the quoted market prices for the same or similar issues.

NOTE 7 – BUSINESS COMBINATION

On May 31, 2021, the Company completed its acquisition (the "MobiTV Acquisition") of certain assets and assumption of certain liabilities of MobiTV, Inc. (“MobiTV”), a provider of application-based Pay-TV video delivery solutions. The MobiTV Acquisition expanded the Company’s IPTV Managed Service capabilities, which is expected to grow the addressable market for the Company’s IPTV products and further secure TiVo’s position as a leading provider of Pay-TV solutions. The net purchase price for the MobiTV Acquisition was $17.4 million in cash.

Purchase Price Allocation

The MobiTV Acquisition has been accounted for as a business combination, using the acquisition method. The following table presents the allocation of the purchase price to the identifiable assets acquired and liabilities assumed based on the fair values at the acquisition date, with any excess of the purchase price over the estimated fair value of the identifiable net assets acquired recorded to goodwill, all of which is expected to be deductible for tax purposes. The following table sets forth the final purchase price allocation with no measure period adjustments identified ($ in thousands):

 

 

 

Estimated Useful
 Life (years)

 

 

 

 

Final
Fair Value

 

Other current assets

 

 

 

 

 

 

$

390

 

Property and equipment

 

 

 

 

 

 

 

9,223

 

Operating lease right-of-use assets

 

 

 

 

 

 

 

1,186

 

Identifiable intangible assets:

 

 

 

 

 

 

 

 

Patents

 

10

 

 

5,000

 

 

 

 

Technology

 

6

 

 

3,260

 

 

 

 

Total identifiable intangible assets

 

 

 

 

 

 

 

8,260

 

Goodwill

 

 

 

 

 

 

 

4,059

 

Other long-term assets

 

 

 

 

 

 

 

115

 

Accrued liabilities

 

 

 

 

 

 

 

(5,288

)

Noncurrent operating lease liabilities

 

 

 

 

 

 

 

(545

)

Total purchase price

 

 

 

 

 

 

$

17,400

 

The results of operations and cash flows relating to the business acquired pursuant to the MobiTV Acquisition have been included in the Company’s consolidated financial statements for periods subsequent to May 31, 2021, and the related assets and liabilities were recorded at their estimated fair values in the Company’s Consolidated Balance Sheet as of May 31, 2021. The operations acquired in the MobiTV Acquisition are included in the Company’s Product segment.

 

21


 

Supplemental Pro Forma Information

The following unaudited pro forma financial information assumes the MobiTV Acquisition was completed as of January 1, 2020. The unaudited pro forma financial information as presented below is for informational purposes only and is based on estimates and assumptions that have been made solely for purposes of developing such pro forma information. This is not necessarily indicative of the results of operations that would have been achieved if the MobiTV Acquisition had taken place on January 1, 2020, nor is it necessarily indicative of future results. Consequently, actual results could differ materially from the unaudited pro forma financial information presented below. The following table presents the pro forma operating results as if the acquired operations of MobiTV had been included in the Company's Condensed Consolidated Statements of Operations as of January 1, 2020 (unaudited, in thousands):

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30, 2021

 

 

June 30, 2021

 

Revenue

 

$

223,363

 

 

$

447,727

 

Net loss attributable to Xperi Holding Corporation

 

$

(8,606

)

 

$

(14,868

)

The unaudited supplemental pro forma information above includes the following pro forma adjustments: removal of certain elements of the historical MobiTV business that were not acquired, elimination of inter-company transactions between MobiTV and TiVo, adjustments for transaction related costs, and adjustments to reflect the impact of purchase accounting adjustments. The unaudited supplemental pro forma information above does not include any cost saving synergies from operating efficiencies.

NOTE 8 – GOODWILL AND IDENTIFIED INTANGIBLE ASSETS

Goodwill

The changes to the carrying value of goodwill from January 1, 2022 through June 30, 2022 are reflected below (in thousands):

 

 

 

 

December 31, 2021

 

$

851,088

 

Goodwill adjustment related to Mergers in prior periods (1)

 

 

(988

)

June 30, 2022 (2)

 

$

850,100

 

(1)
The change to the carrying value of goodwill from December 31, 2021 through June 30, 2022 was an immaterial measurement period adjustment.
(2)
The Company's reporting units include the IP Licensing segment and the Product segment (defined further in “Note 16 - Segment and Geographic Information”). Of the carrying value of goodwill, approximately $322.3 million was allocated to the IP Licensing segment and approximately $527.8 million was allocated to the Product segment as of June 30, 2022.

 

Goodwill at each reporting unit is evaluated for potential impairment annually, as of the beginning of the fourth quarter, and whenever events or changes in circumstances indicate the carrying amount of goodwill may not be recoverable.

22


 

Identified Intangible Assets

Identified intangible assets consisted of the following (in thousands):

 

 

 

Average

 

June 30, 2022

 

 

December 31, 2021

 

 

 

Life
(Years)

 

Gross
Assets

 

 

Accumulated
Amortization

 

 

Net

 

 

Gross
Assets

 

 

Accumulated
Amortization

 

 

Net

 

Finite-lived intangible assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquired patents / core technology

 

3-10

 

$

673,032

 

 

$

(252,980

)

 

$

420,052

 

 

$

672,872

 

 

$

(224,508

)

 

$

448,364

 

Existing technology / content database

 

5-10

 

 

251,388

 

 

 

(216,411

)

 

 

34,977

 

 

 

251,445

 

 

 

(206,934

)

 

 

44,511

 

Customer contracts and related relationships

 

3-9

 

 

649,637

 

 

 

(398,462

)

 

 

251,175

 

 

 

649,926

 

 

 

(360,543

)

 

 

289,383

 

Trademarks/trade name

 

4-10

 

 

40,083

 

 

 

(28,333

)

 

 

11,750

 

 

 

40,083

 

 

 

(25,825

)

 

 

14,258

 

Non-competition agreements

 

1

 

 

2,231

 

 

 

(2,231

)

 

 

 

 

 

2,231

 

 

 

(2,231

)

 

 

 

Total finite-lived intangible assets

 

 

 

 

1,616,371

 

 

 

(898,417

)

 

 

717,954

 

 

 

1,616,557

 

 

 

(820,041

)

 

 

796,516

 

Indefinite-lived intangible assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TiVo Tradename/trademarks

 

N/A

 

 

21,400

 

 

 

 

 

 

21,400

 

 

 

21,400

 

 

 

 

 

 

21,400

 

Total intangible assets

 

 

 

$

1,637,771

 

 

$

(898,417

)

 

$

739,354

 

 

$

1,637,957

 

 

$

(820,041

)

 

$

817,916

 

 

As of June 30, 2022, the estimated future amortization expense of total finite-lived intangible assets was as follows (in thousands):

 

2022 (remaining 6 months)

 

$

77,558

 

2023

 

 

145,092

 

2024

 

 

106,178

 

2025

 

 

81,673

 

2026

 

 

78,727

 

Thereafter

 

 

228,726

 

 

 

$

717,954

 

 

NOTE 9 – DEBT

The outstanding amounts of debt were as follows (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Refinanced Term B Loans

 

$

769,500

 

 

$

789,750

 

Unamortized debt discount and issuance costs

 

 

(22,031

)

 

 

(24,263

)

 

 

 

747,469

 

 

 

765,487

 

Less: current portion, net of debt discount and issuance costs

 

 

(36,210

)

 

 

(36,095

)

Total long-term debt, net of current portion

 

$

711,259

 

 

$

729,392

 

 

23


 

Refinanced Term B Loans

 

On June 8, 2021, the Company amended that certain Credit Agreement dated June 1, 2020 by and among the Company, the lenders party thereto and Bank of America, N.A., as administrative agent and collateral agent (the “2020 Credit Agreement”). The 2020 Credit Agreement initially provided for a five-year senior secured term B loan facility in an aggregate principal amount of $1,050 million (the “2020 Term B Loan Facility”). In connection with the amendment (the “Amendment”), the Company made a voluntary prepayment of $50.6 million of the term loan outstanding under the 2020 Credit Agreement using cash on hand. The Amendment provided for, among other things, (i) a new tranche of term loans (the “Refinanced Term B Loans”) in an aggregate principal amount of $810.0 million, (ii) a reduction of the interest rate margin applicable to such loans to (x) in the case of base rate loans, 2.50% per annum and (y) in the case of Eurodollar loans, LIBOR plus a margin of 3.50% per annum, (iii) a prepayment premium of 1.00% in connection with any repricing transaction with respect to the Refinanced Term B Loans within six months of the closing date of the Amendment, (iv) an extension of the maturity to June 8, 2028, and (v) certain additional amendments, including amendments to provide the Company with additional flexibility under the covenant governing restricted payments. The Company commenced repaying quarterly installments under the Refinanced Term B Loans in the third quarter of 2021.

 

The obligations under the 2020 Credit Agreement, inclusive of any changes by the Amendment, continue to be guaranteed by Xperi, TiVo and certain other of the Company’s wholly-owned material domestic subsidiaries (collectively, the “Guarantors”) and continue to be secured by a lien on substantially all of the assets of the Company and the Guarantors.

 

The 2020 Credit Agreement, as amended, contains customary events of default, upon the occurrence of which, after any applicable cure period, the lenders will have the ability to accelerate all outstanding loans thereunder. The 2020 Credit Agreement, as amended, also contains customary representations and warranties and affirmative and negative covenants that, among other things and subject to certain exceptions, restrict the ability of the Company and its subsidiaries to create or

incur certain liens, incur or guarantee additional indebtedness, merge or consolidate with other companies, transfer or sell assets and make restricted payments. The 2020 Credit Agreement, as amended, requires the Company to maintain a total net leverage ratio of no greater than 3.00x in order access an annual basket from which to make restricted payments (such as dividend payments and share repurchases). The Company was in compliance with all requirements as of June 30, 2022. The 2020 Credit Agreement, as amended, also requires the Company to make additional cash payments on an annual basis beginning in March 2023 based on certain leverage ratios and excess cash flow generated for the immediately preceding fiscal year.

 

Certain lenders of the 2020 Term B Loan Facility participated in the Amendment and the changes in terms were not considered substantial. Accordingly, the Company accounted for the refinancing event for these lenders as a debt modification under ASC 470-50, “Debt — Modifications and Extinguishments.” Under its policy, the Company elected to continue to defer the unamortized debt discount and issuance costs for these continuing lenders related to the partial pay-down of the debt. Certain lenders of the 2020 Term B Loan Facility did not participate in the Amendment. Accordingly, the Company accounted for the refinancing event for these lenders as a debt extinguishment. As a result, the Company recorded an $8.0 million loss on debt extinguishment in the second quarter of 2021, related to the write-off of unamortized debt discount and issuance costs for the portions of the 2020 Term B Loan Facility considered to be extinguished.

 

In connection with its entry into the Amendment, the Company incurred $6.8 million in debt financing costs, of which $4.2 million were capitalized in accordance with ASC 835-30 “Debt Issuance Costs” and, together with a portion of the unamortized debt discount and issuance costs from the 2020 Term B Loan Facility, are being amortized into interest expense over the term of the Amendment. Under ASC 470-50, the remaining $2.6 million, primarily related to third-party fees, were recorded as selling, general and administrative expense in the second quarter of 2021.

Interest Expense and Expected Principal Payments

At June 30, 2022, $769.5 million in total debt was outstanding. There were also $22.0 million of unamortized debt discount and issuance costs recorded as a reduction from the carrying amount of the debt. Interest rate on the Refinanced Term B Loans, including the amortization of debt discount and issuance costs was 4.6% and interest was payable monthly. Interest expense was $9.4 million and $17.9 million for the three and six months ended June 30, 2022, respectively. Interest expense was $10.6 million and $21.9 million for the three and six months ended June 30, 2021, respectively. Amortized debt discount and issuance costs, which were included in interest expense, amounted to $1.1 million and $2.2 million for the three and six months ended June 30, 2022, respectively, and $1.9 million and $4.1 million for the three and six months ended June 30, 2021, respectively.

24


 

As of June 30, 2022, future minimum principal payments for long-term debt are summarized as follows (in thousands):

 

2022 (remaining 6 months)

 

$

20,250

 

2023

 

 

40,500

 

2024

 

 

40,500

 

2025

 

 

40,500

 

2026

 

 

40,500

 

Thereafter

 

 

587,250

 

Total

 

$

769,500

 

 

NOTE 10 – NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted shares (in thousands):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock outstanding

 

 

104,001

 

 

 

104,906

 

 

 

103,841

 

 

 

104,923

 

Total common shares-basic

 

 

104,001

 

 

 

104,906

 

 

 

103,841

 

 

 

104,923

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Options

 

 

 

 

 

 

 

 

 

 

 

29

 

Restricted stock awards and units

 

 

 

 

 

 

 

 

1,521

 

 

 

2,715

 

Total common shares-diluted

 

 

104,001

 

 

 

104,906

 

 

 

105,362

 

 

 

107,667

 

 

Basic net income per share is computed using the weighted average number of shares of common stock outstanding during the period, excluding any unvested restricted stock awards that are subject to repurchase. Diluted net income per share is computed using the treasury stock method to calculate the weighted average number of shares of common stock and, if dilutive, potential common shares outstanding during the period. Potentially dilutive common shares include unvested restricted stock awards and units and incremental common shares issuable upon the exercise of stock options, less shares repurchased from assumed proceeds. The assumed proceeds calculation includes actual proceeds to be received from the employee upon exercise and the average unrecognized stock compensation cost during the period.

For the three months ended June 30, 2022 and 2021, there was no difference in the weighted average number of common shares used for the calculation of basic and diluted loss per share as the effect of all potentially dilutive shares outstanding was anti-dilutive. A total of 7.9 million shares and 5.8 million shares, subject to stock options and restricted stock awards and units, were excluded from the computation of diluted net loss per share for the three months ended June 30, 2022 and 2021, respectively, because including them would have been anti-dilutive.

For the six months ended June 30, 2022 and 2021, 3.8 million and 2.1 million shares, respectively, subject to stock options and restricted stock awards and units were excluded from the computation of diluted net income per share as they were anti-dilutive.

NOTE 11 – STOCKHOLDERS’ EQUITY

Equity Incentive Plans

The 2020 EIP

In connection with the Mergers and immediately prior to June 1, 2020, the Company adopted the Xperi Holding Corporation 2020 Equity Incentive Plan (the “2020 EIP”). Under the 2020 EIP, the Company may grant equity-based awards to employees, non-employee directors, and consultants for services rendered to the Company (or any parent or subsidiary) in the form of stock options, stock awards, restricted stock awards, restricted stock units, stock appreciation rights, dividend equivalents and performance awards (or any combination thereof). A total of 16,800,000 shares have been reserved for issuance under the 2020 EIP provided that each share issued pursuant to “full value” awards (i.e., stock awards, restricted stock awards, restricted stock units, performance awards and dividend equivalents) are counted against shares available for issuance under the 2020 EIP on a 1.5 to 1 ratio. At the 2022 Annual Stockholders Meeting on April 29, 2022, the Company's shareholders approved an amendment to the 2020 EIP and increased by 8.8 million the number of shares reserved for issuance.

25


 

The 2020 EIP provides for option grants designed as either incentive stock options or nonstatutory options. Options generally are granted with an exercise price not less than the value of the common stock on the grant date and have a term of ten years from the date of grant and vest over a four-year period. The vesting criteria for restricted stock awards and restricted stock units is generally the passage of time or meeting certain performance-based objectives, and continued employment through the vesting period generally over four years for time-based awards.

Assumed Plans

On June 1, 2020, the Company assumed all then-outstanding stock options, awards, and shares available and reserved for issuance under all legacy Equity Incentive Plans of TiVo (collectively, the “Assumed Plans”). Stock options assumed from the Assumed Plans generally have vesting periods of four years and a contractual term of seven years. Awards of restricted stock and restricted stock units assumed from the Assumed Plans are generally subject to a four year vesting period. The number of shares subject to stock options and restricted stock unit awards outstanding under these plans are included in the tables below. Shares reserved under the Assumed Plans will be available for future grants.

As of June 30, 2022, there were 6.4 million shares reserved for future grants under both the 2020 EIP and the Assumed Plans.

A summary of the stock option activity is presented below (in thousands, except per share amounts):

 

 

 

Options Outstanding

 

 

 

Number of
Shares
Subject
to Options

 

 

Weighted
Average
Exercise
Price Per
Share

 

Balance at December 31, 2021

 

 

447

 

 

$

25.22

 

Options granted

 

 

 

 

$

 

Options exercised

 

 

(4

)

 

$

14.58

 

Options canceled / forfeited / expired

 

 

(48

)

 

$

43.95

 

Balance at June 30, 2022

 

 

395

 

 

$

23.06

 

 

Restricted Stock Awards and Units

Information with respect to outstanding restricted stock awards and units (including both time-based vesting and performance-based vesting) as of June 30, 2022 is as follows (in thousands, except per share amounts):

 

 

 

Restricted Stock and Restricted Stock Units

 

 

 

Number of
Shares
Subject to
Time-
based Vesting

 

 

Number of
Shares
Subject to
Performance-
based Vesting

 

 

Total
Number of
Shares

 

 

Weighted
Average
Grant Date
Fair Value
Per Share

 

Balance at December 31, 2021

 

 

6,815

 

 

 

1,525

 

 

 

8,340

 

 

$

19.61

 

Awards and units granted

 

 

4,147

 

 

 

803

 

 

 

4,950

 

 

$

16.85

 

Awards and units vested / earned

 

 

(1,403

)

 

 

(335

)

 

 

(1,738

)

 

$

20.81

 

Awards and units canceled / forfeited

 

 

(616

)

 

 

(174

)

 

 

(790

)

 

$

19.05

 

Balance at June 30, 2022

 

 

8,943

 

 

 

1,819

 

 

 

10,762

 

 

$

18.19

 

 

Performance Awards and Units

Performance awards and units may be granted to employees or consultants based upon, among other things, the contributions, responsibilities and other compensation of the particular employee or consultant. The value and the vesting of such performance awards and units are generally linked to one or more performance goals or certain market conditions determined by the Company, in each case on a specified date or dates or over any period or periods determined by the Company, and may range from zero to 200 percent of the grant. For performance awards subject to a market vesting condition (“market-based PSUs”), the fair value per award is fixed at the grant date and the amount of compensation expense is not adjusted during the performance period regardless of changes in the level of achievement of the market condition.

26


 

Employee Stock Purchase Plans

Prior to the Mergers, the Company had implemented the Xperi Corporation 2003 Employee Stock Purchase Plan and the International Employee Stock Purchase Plan, both of which were terminated immediately prior to the effective time of the Mergers.

In connection with the Mergers and immediately prior to June 1, 2020, the Company adopted the Xperi Holding Corporation 2020 Employee Stock Purchase Plan (the “2020 ESPP”). The 2020 ESPP is implemented through consecutive overlapping 24-month offering periods, each of which is comprised of four six-month purchase periods. The first offering period commenced on September 1, 2020 and will end on August 31, 2022. Each subsequent offering period under the 2020 ESPP will be twenty-four (24) months long and will commence on each September 1 and March 1 during the term of the plan. Participants may contribute up to 100% of their base earnings and commissions through payroll deductions, and the accumulated deductions will be applied to the purchase of shares on each semi-annual purchase date. The purchase price per share will equal 85% of the fair market value per share on the start date of the offering period or, if lower, 85% of the fair market value per share on the semi-annual purchase date.

An eligible employee’s right to buy the Company’s common stock under the 2020 ESPP may not accrue at a rate in excess of $25,000 of the fair market value of such shares per calendar year for each calendar year of an offering period. If the fair market value per share of the Company’s common stock on any purchase date during an offering period is less than the fair market value per share on the start date of the 24-month offering period, then that offering period will automatically terminate and a new 24-month offering period will begin on the next business day. All participants in the terminated offering will be transferred to the new offering period.

As of June 30, 2022, there were 6.1 million shares reserved for grant under the Company’s 2020 ESPP. At the 2022 Annual Stockholders Meeting on April 29, 2022, the Company's shareholders approved an amendment to the 2020 ESPP and increased by 6.0 million the number of shares reserved for issuance.

Stock Repurchase Programs

Following the termination of Xperi’s prior stock repurchase program after the closing of the Mergers, on June 12, 2020 the Board of Directors (the “Board”) of the Company authorized a new stock repurchase program providing for the repurchase of up to $150.0 million of the Company's Common Stock dependent on market conditions, share prices and other factors. On April 22, 2021, the Board authorized an additional $100.0 million of purchases under the existing stock repurchase plan.

As of June 30, 2022, the Company has repurchased a total of approximately 10.0 million shares of common stock, since inception of the plan, at an average price of $17.24 per share for a total cost of $172.2 million. As of December 31, 2021, the Company had repurchased a total of approximately 9.0 million shares of common stock, since inception of the plan, at an average price of $17.29 per share for a total cost of $155.0 million. The shares repurchased are recorded as treasury stock and are accounted for under the cost method. No expiration date has been specified for this plan. As of June 30, 2022, the total remaining amount available for repurchase under this plan was $77.8 million. The Company plans to continue to execute authorized repurchases from time to time under the plan.

The Company issues restricted stock units as part of the equity incentive plans described above. For the majority of restricted awards, shares are withheld to satisfy required withholding taxes at the vesting date. Shares withheld to satisfy required withholding taxes in connection with the vesting of restricted awards are treated as common stock repurchases in the condensed consolidated financial statements because they reduce the number of shares that would have been issued on vesting. However, these withheld shares are not included in common stock repurchases under the Company's authorized share repurchase plan. During the three months ended June 30, 2022 and 2021, the Company withheld 0.1 million and 0.1 million shares of common stock to satisfy $0.4 million and $1.0 million of required withholding taxes, respectively. During the six months ended June 30, 2022 and 2021, the Company withheld 0.7 million and 0.4 million shares of common stock to satisfy $11.5 million and $8.3 million of required withholding taxes, respectively.

27


 

NOTE 12 – STOCK-BASED COMPENSATION EXPENSE

The effect of recording stock-based compensation (“SBC”) expense for the three and six months ended June 30, 2022 and 2021 is as follows (in thousands):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Cost of revenue, excluding depreciation and amortization of intangible assets

 

$

773

 

 

$

529

 

 

$

1,401

 

 

$

852

 

Research, development and other related costs

 

 

6,074

 

 

 

4,810

 

 

 

11,548

 

 

 

9,157

 

Selling, general and administrative

 

 

8,634

 

 

 

9,496

 

 

 

19,335

 

 

 

18,045

 

Total stock-based compensation expense

 

 

15,481

 

 

 

14,835

 

 

 

32,284

 

 

 

28,054

 

Tax effect on stock-based compensation expense

 

 

(127

)

 

 

(180

)

 

 

(299

)

 

 

(334

)

Net effect on net income (loss)

 

$

15,354

 

 

$

14,655

 

 

$

31,985

 

 

$

27,720

 

SBC expense categorized by various equity components for the three and six months ended June 30, 2022 and 2021 is summarized in the table below (in thousands):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Restricted stock awards and units

 

$

14,044

 

 

$

13,400

 

 

$

29,263

 

 

$

25,330

 

Employee stock purchase plan

 

 

1,437

 

 

 

1,414

 

 

 

3,021

 

 

 

2,684

 

Employee stock options

 

 

 

 

 

21

 

 

 

 

 

 

40

 

Total stock-based compensation expense

 

$

15,481

 

 

$

14,835

 

 

$

32,284

 

 

$

28,054

 

In connection with termination of employment with a former executive on March 1, 2022, the Company entered into a Separation Agreement and Release with the executive, dated February 18, 2022 (the “Separation Agreement”). Pursuant to the Separation Agreement, the Company approved, among other severance benefits, accelerated vesting of 372,244 of outstanding performance and time-based restricted stock units. As a result of this modification, the Company recorded incremental SBC of approximately $2.2 million for the three months ended March 31, 2022.

There were no options granted in the three and six months ended June 30, 2022 and 2021.

 

The following assumptions were used to value the restricted stock units subject to market conditions granted during the period:

 

 

 

June 2022

 

 

April 2022

 

 

March 2021

 

Expected life (years)

 

 

3.0

 

 

 

3.0

 

 

 

3.0

 

Risk-free interest rate

 

 

2.8

%

 

 

2.8

%

 

 

0.3

%

Dividend yield

 

 

1.2

%

 

 

1.2

%

 

 

1.0

%

Expected volatility

 

 

37.5

%

 

 

40.9

%

 

 

47.9

%

 

ESPP grants occur in March and September. The following assumptions were used to value the ESPP shares for these grants:

 

 

 

March 2022

 

 

September 2021

 

 

March 2021

 

Expected life (years)

 

 

2.0

 

 

 

2.0

 

 

 

2.0

 

Risk-free interest rate

 

 

1.3

%

 

 

0.2

%

 

 

0.1

%

Dividend yield

 

 

1.1

%

 

 

0.9

%

 

 

1.2

%

Expected volatility

 

 

48.5

%

 

 

52.0

%

 

 

52.0

%

 

 

28


 

NOTE 13 – INCOME TAXES

For the three months ended June 30, 2022, the Company recorded an income tax expense of $22.1 million on pretax income of $15.7 million, and for the six months ended June 30, 2022 the Company recorded an income tax expense of $43.7 million on pretax income of $61.2 million, which resulted in an effective tax rate of 71.4% for the six months ended June 30, 2022. The income tax expense for the three and six months ended June 30, 2022 was primarily related to foreign withholding taxes, U.S. federal income tax, state income taxes, and unrealized foreign exchange loss from the prior year South Korea refund claims. The Company's effective tax rate was based on a projected 2022 GAAP pretax profit and is significantly higher than the 21% U.S. federal tax rate. The Company's effective tax rate varies period over period because the most significant components of tax expense, foreign withholding taxes and foreign exchange gains or losses on the Korea withholding tax refund claims, are not directly affected by changes in pre-tax income.

For the three months ended June 30, 2021, the Company recorded an income tax benefit of $2.9 million on pretax loss of $4.7 million and for the six months ended June 30, 2021, the Company recorded an income tax benefit of $6.9 million on a pretax loss of $4.2 million, which resulted in an effective tax rate of 162.6% for the six months ended June 30, 2021. The income tax benefit for the three and six months ended June 30, 2021 was primarily related to foreign withholding taxes, U.S. federal base erosion and anti-abuse tax (“BEAT”) and unrealized foreign exchange loss from the prior year South Korea refund claims. The Company’s effective tax rate was based on the projected 2021 GAAP U.S. pretax loss and is significantly higher than the 21% U.S. federal tax rate. The Company's effective tax rate is the result of the most significant components of income tax expense, primarily driven by foreign withholding and BEAT. The computed effective tax rate is applied to the year-to-date U.S. profit resulting in an income tax benefit for the quarter ended June 30, 2021.

As of June 30, 2022, gross unrecognized tax benefits, excluding interest and penalties, were $240.4 million compared to $240.4 million as of December 31, 2021. This was included in long-term deferred tax and other long-term liabilities on the Condensed Consolidated Balance Sheets. Of this amount, $95.1 million would affect the effective tax rate if recognized. As of June 30, 2021, unrecognized tax benefits, excluding interest and penalties, of $233.9 million were included in long-term deferred tax and other long-term liabilities on the Condensed Consolidated Balance Sheets. Of this amount, $92.6 million would affect the effective tax rate if recognized. The Company is unable to reasonably estimate the timing of the long-term payments or the amount by which the liability will increase or decrease.

It is the Company's policy to classify accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. The Company recognized interest and penalties related to unrecognized tax benefits of $0.6 million and $0.8 million for the six months ended June 30, 2022 and 2021, respectively. Accrued interest and penalties were $3.4 million and $2.8 million as of June 30, 2022 and December 31, 2021, respectively.

As of June 30, 2022, the Company’s 2017 through 2021 tax years are generally open and subject to potential examination in one or more jurisdictions. Earlier tax years for the Company and its subsidiaries are also open in certain jurisdictions which are currently subject to examination. In addition, in the U.S., any net operating losses or credits that were generated in prior years but not yet fully utilized in a year that is closed under the statute of limitations may also be subject to examination. The Company has submitted a withholding tax refund claim with the South Korean authorities and the final outcome is not anticipated to be settled within the next twelve months.

NOTE 14 – LEASES

The Company leases office and research facilities, data centers and office equipment under operating leases which expire through 2029. The Company’s leases have remaining lease terms of one year to eight years, some of which may include options to extend the leases for five years or longer, and some of which may include options to terminate the leases within the next 7 years or less. Leases with an initial term of 12 months or less are not recorded on the balance sheets; expense for these leases is recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the lease liability and right-of-use assets calculation. As a practical expedient, the Company elected, for all office and facility leases, not to separate non-lease components (e.g., common-area maintenance costs) from lease components (e.g., fixed payments including rent) and instead to account for each separate lease component and its associated non-lease components as a single lease component. As most of the leases do not provide an implicit rate, the Company generally, for purposes of discounting lease payments, uses its incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date.

The Company subleases certain real estate to third parties. The sublease portfolio consists of operating leases for previously exited office space. Certain subleases include variable payments for operating costs. The subleases are generally co-terminus with the head lease, or shorter. Subleases do not include any residual value guarantees or restrictions or covenants imposed by the leases. Income from subleases is recognized as a reduction to selling, general and administrative expenses.

29


 

The components of operating lease costs were as follows (in thousands):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Fixed lease cost (1)

 

$

5,463

 

 

$

5,528

 

 

$

10,989

 

 

$

10,994

 

Variable lease cost

 

 

1,506

 

 

 

1,187

 

 

 

2,780

 

 

 

2,552

 

Less: sublease income

 

 

(2,705

)

 

 

(3,157

)

 

 

(4,811

)

 

 

(5,346

)

Total operating lease cost

 

$

4,264

 

 

$

3,558

 

 

$

8,958

 

 

$

8,200

 

 

(1) Includes short-term leases, which were immaterial.

Other information related to leases was as follows (in thousands, except lease term and discount rate):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Operating cash flows from operating leases

 

$

5,439

 

 

$

5,761

 

 

$

11,024

 

 

$

11,316

 

ROU assets obtained in exchange for new lease liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Operating leases

 

$

1,195

 

 

$

3,478

 

 

$

3,103

 

 

$

3,478

 

 

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Weighted-average remaining lease term (years):

 

 

 

 

 

 

Operating leases

 

 

4.0

 

 

 

4.4

 

Weighted-average discount rate:

 

 

 

 

 

 

Operating leases

 

 

4.9

%

 

 

5.0

%

 

Future minimum lease payments and related lease liabilities as of June 30, 2022 were as follows (in thousands):

 

 

 

Operating Lease Payments (1)

 

 

Sublease Income

 

 

Net Operating Lease Payments

 

2022 (remaining 6 months)

 

$

9,313

 

 

$

(3,735

)

 

$

5,578

 

2023

 

 

19,585

 

 

 

(7,618

)

 

$

11,967

 

2024

 

 

17,681

 

 

 

(7,610

)

 

$

10,071

 

2025

 

 

15,516

 

 

 

(7,386

)

 

$

8,130

 

2026

 

 

6,586

 

 

 

(935

)

 

$

5,651

 

Thereafter

 

 

3,182

 

 

 

 

 

$

3,182

 

Total lease payments

 

 

71,863

 

 

 

(27,284

)

 

 

44,579

 

Less: imputed interest

 

 

(7,092

)

 

 

 

 

 

(7,092

)

Present value of lease liabilities:

 

$

64,771

 

 

$

(27,284

)

 

$

37,487

 

 

 

 

 

 

 

 

 

 

 

Less: current obligations under leases (accrued liabilities)

 

 

16,319

 

 

 

 

 

 

 

Noncurrent operating lease liabilities

 

$

48,452

 

 

 

 

 

 

 

(1) Future minimum lease payments exclude short-term leases as well as payments to landlords for variable common area maintenance, insurance and real estate taxes.

 

 

30


 

NOTE 15 – COMMITMENTS AND CONTINGENCIES

 

Purchase and Other Contractual Obligations

 

In the ordinary course of business, the Company enters into contractual agreements with third parties that include non-cancelable payment obligations, for which it is liable in future periods. These arrangements primarily include unconditional purchase obligations to service providers. As of June 30, 2022, the Company’s total future unconditional purchase obligations were approximately $114.5 million.

Inventory Purchase Commitment

The Company uses contract manufacturers to provide manufacturing services for its products. During the normal course of business, in order to manage manufacturing lead times and help ensure adequate supply, the Company enters into agreements with its contract manufacturers that either allow them to procure inventory based on criteria as defined by the Company or that establish the parameters defining the Company’s requirements. A significant portion of the Company’s purchase commitments arising from these agreements consist of firm, non-cancelable and unconditional purchase commitments. In certain instances, these agreements allow the Company the option to cancel, reschedule or adjust the Company’s requirements based on its business needs prior to firm orders being placed. As of June 30, 2022, the Company had total purchase commitments for inventory of $5.5 million, of which $1.5 million was accrued in the Condensed Consolidated Balance Sheet.

Indemnifications

In the normal course of business, the Company provides indemnifications of varying scopes and amounts to certain of its licensees, customers, and business partners against claims made by third parties arising from the use of the Company's products, intellectual property, services or technologies. The Company cannot reasonably estimate the possible range of losses that may be incurred pursuant to its indemnification obligations, if any. Variables affecting any such assessment include, but are not limited to: the nature of the claim asserted; the relative merits of the claim; the financial ability of the party suing the indemnified party to engage in protracted litigation; the number of parties seeking indemnification; the nature and amount of damages claimed by the party suing the indemnified party; and the willingness of such party to engage in settlement negotiations. To date, no such claims have been filed against the Company and no liability has been recorded in the Company’s financial statements.

As permitted under Delaware law, the Company has agreements whereby it indemnifies its officers and directors for certain events or occurrences while the officer or director is, or was, serving at the Company’s request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company believes, given the absence of any such payments in the Company’s history, and the estimated low probability of such payments in the future, that the estimated fair value of these indemnification agreements is immaterial. In addition, the Company has directors’ and officers’ liability insurance coverage that is intended to reduce its financial exposure and may enable the Company to recover any payments under the indemnification agreements, should they occur.

Contingencies

At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of losses is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies.

On June 23, 2017, Rovi Guides, Inc. and TiVo Solutions Inc. (together, “TiVo”) filed a patent infringement complaint against Videotron Ltd. and Videotron G.P. (together, “Videotron”) in Toronto, Canada, alleging infringement of six patents (“Videotron 1”). Videotron was a prior licensee under the Rovi patent portfolio. On June 10, 2022, the Court issued its decision in the case finding in favor of Videotron and its legacy illico platform. Specifically, the Court found invalid each of the asserted claims of the four patents involved in the case. In Canada, the prevailing party in patent litigation is entitled to reimbursement of certain of its costs and expenses. Accordingly, while the exact reimbursement amount has yet to be determined, we have accrued $2.2 million for estimated expense reimbursement as of June 30, 2022. This amount is included in litigation expense for the three and six months ended June 30, 2022.

The Company is currently unable to predict the final outcome of other lawsuits, including other patent infringement lawsuits in Canada, to which it is a party and therefore cannot determine the likelihood of loss nor estimate a range of possible losses. An adverse decision in any of these proceedings could significantly harm the Company’s business and consolidated financial position, results of operations or cash flows.

31


 

The Company and its subsidiaries are involved in litigation matters and claims in the normal course of business. In the past, the Company and its subsidiaries have litigated to enforce their respective patents and other intellectual property rights, to enforce the terms of license agreements, to protect trade secrets, to determine the validity and scope of the proprietary rights of others and to defend itself or its customers against claims of infringement or invalidity. The Company expects it or its subsidiaries will be involved in similar legal proceedings in the future, including proceedings regarding infringement of its patents, and proceedings to ensure proper and full payment of royalties by licensees under the terms of its license agreements.

The existing and any future legal actions may harm the Company’s business. For example, legal actions could cause an existing licensee or strategic partner to cease making royalty or other payments to the Company, or to challenge the validity and enforceability of patents owned by the Company’s subsidiaries or the scope of license agreements with the Company’s subsidiaries, or could significantly damage the Company’s relationship with such licensee or strategic partner and, as a result, prevent the adoption of the Company’s other technologies by such licensee or strategic partner. Litigation could also severely disrupt or shut down the business operations of licensees or strategic partners of the Company’s subsidiaries, which in turn would significantly harm ongoing relations with them and cause the Company to lose royalty revenue.

The costs associated with legal proceedings are typically high, relatively unpredictable, and not completely within the Company’s control. These costs may be materially higher than expected, which could adversely affect the Company’s operating results and lead to volatility in the price of its common stock. Whether or not determined in the Company’s favor or ultimately settled, litigation diverts managerial, technical, legal, and financial resources from the Company’s business operations. Furthermore, an adverse decision in any of these legal actions could result in a loss of the Company’s proprietary rights, subject the Company to significant liabilities, require the Company to seek licenses from others, limit the value of the Company’s licensed technology or otherwise negatively impact the Company’s stock price or its business and consolidated financial results.

NOTE 16 – SEGMENT AND GEOGRAPHIC INFORMATION

The Company reports its financial results within two reportable segments: (1) Intellectual Property (“IP”) Licensing and (2) Product. There are certain corporate overhead costs that are not allocated to these reportable segments because these operating amounts are not considered in evaluating the operating performance of the Company’s business segments.

Reportable segments are identified based on the Company's organizational structure and information reviewed by the Company’s chief operating decision maker (“CODM”) to evaluate performance and allocate resources. The Company’s Chief Executive Officer is also the CODM as defined by the authoritative guidance on segment reporting.

 

The IP Licensing segment consists primarily of licensing the Company’s innovations to leading companies in the broader entertainment and semiconductor industries, and those developing new technologies that will help drive the industries forward. Licensing arrangements include access to one or more of the Company’s foundational patent portfolios and may also include access to some of its industry-leading technologies and proven know-how.

 

In its Product segment, the Company derives the majority of its revenue from licensing its technology to customers primarily through Technology License arrangements and Technology Solutions arrangements. For Technology License arrangements, the customer obtains rights to the technology delivered at the commencement of the agreement. For Technology Solutions arrangements, the customer receives access to a platform, media or data that includes frequent updates, where access to such updates is critical to the functionality of the technology.

The Company does not identify or allocate assets by reportable segment, nor does the CODM evaluate reportable segments using discrete asset information. Reportable segments do not record inter-segment revenue and accordingly there are none to report. The Company does not allocate other income and expense to reportable segments. Although the CODM uses operating income to evaluate reportable segments, operating costs included in one segment may benefit other segments.

32


 

The following table sets forth the Company’s segment revenue, operating expenses and operating income for the three and six months ended June 30, 2022 and 2021 (in thousands):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

IP Licensing segment

 

$

107,815

 

 

$

101,846

 

 

$

246,346

 

 

$

199,860

 

Product segment

 

 

126,203

 

 

 

120,426

 

 

 

245,092

 

 

 

244,008

 

Total revenue

 

 

234,018

 

 

 

222,272

 

 

 

491,438

 

 

 

443,868

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

IP Licensing segment

 

 

38,474

 

 

 

34,875

 

 

 

73,766

 

 

 

68,442

 

Product segment

 

 

97,404

 

 

 

105,047

 

 

 

194,915

 

 

 

213,579

 

Unallocated operating expenses (1)

 

 

73,289

 

 

 

69,096

 

 

 

144,937

 

 

 

138,194

 

Total operating expenses

 

 

209,167

 

 

 

209,018

 

 

 

413,618

 

 

 

420,215

 

Operating income:

 

 

 

 

 

 

 

 

 

 

 

 

IP Licensing segment

 

 

69,341

 

 

 

66,971

 

 

 

172,580

 

 

 

131,418

 

Product segment

 

 

28,799

 

 

 

15,379

 

 

 

50,177

 

 

 

30,429

 

Unallocated operating expenses (1)

 

 

(73,289

)

 

 

(69,096

)

 

 

(144,937

)

 

 

(138,194

)

Total operating income

 

$

24,851

 

 

$

13,254

 

 

$

77,820

 

 

$

23,653

 

 

(1)
Unallocated operating expenses consist primarily of selling, marketing, general and administrative expenses, such as administration, human resources, finance, information technology, corporate development and procurement. These expenses are not allocated because these amounts are not considered in evaluating the operating performance of the Company’s business segments.

A significant portion of the Company’s revenue is derived from licensees headquartered outside of the U.S., and it is expected that this revenue will continue to account for a significant portion of total revenue in future periods. The table below lists the geographic revenue for the periods indicated (in thousands):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

U.S.

 

 

170,757

 

 

 

73

%

 

$

141,510

 

 

 

64

%

 

 

353,603

 

 

 

72

%

 

$

273,008

 

 

 

62

%

Japan

 

 

19,520

 

 

 

8

 

 

 

24,258

 

 

 

11

 

 

 

38,404

 

 

 

8

 

 

 

50,702

 

 

 

11

 

South Korea

 

 

8,546

 

 

 

4

 

 

 

15,273

 

 

 

7

 

 

 

15,603

 

 

 

3

 

 

 

33,786

 

 

 

8

 

Europe and Middle East

 

 

8,787

 

 

 

4

 

 

 

14,849

 

 

 

6

 

 

 

21,807

 

 

 

4

 

 

 

31,270

 

 

 

7

 

Other

 

 

26,408

 

 

 

11

 

 

 

26,382

 

 

 

12

 

 

 

62,021

 

 

 

13

 

 

 

55,102

 

 

 

12

 

 

 

$

234,018

 

 

 

100

%

 

$

222,272

 

 

 

100

%

 

$

491,438

 

 

 

100

%

 

$

443,868

 

 

 

100

%

For the three months ended June 30, 2022 and 2021, there were one customer and no customers, respectively, that each accounted for 10% or more of total revenue. For the six months ended June 30, 2022 and 2021, there were two customers and no customers, respectively, that each accounted for 10% or more of total revenue. As of both June 30, 2022 and December 31, 2021, there were two customers and one customer that individually accounted for 10% or more of total accounts receivable.

NOTE 17 - SUBSEQUENT EVENTS

On July 1, 2022, the Company completed the acquisition ("Vewd Acquisition") of Vewd Software Holdings Limited ("Vewd") for total consideration of approximately $109 million, consisting of approximately $59 million of cash and $50 million of debt. The term of the debt is 3 years with a fixed interest rate of 6%. Vewd is a leading global provider of over-the-top (“OTT”) and hybrid TV solutions. The Company is currently evaluating the purchase price allocation following the consummation of the Vewd Acquisition. It is not practicable to disclose the preliminary purchase price allocation or unaudited pro forma financial information for this transaction, given the short period of time between the acquisition date and the issuance of the Condensed Consolidated Financial Statements. The operations acquired in the Vewd Acquisition will be included in the Company’s Product segment.

On July 29, 2022, the Board declared a cash dividend of $0.05 per share of common stock, payable on September 19, 2022 to the stockholders of record at the close of business on August 29, 2022.

33


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion is intended to promote understanding of the results of operations and financial condition and should be read in conjunction with the attached unaudited condensed consolidated financial statements and notes thereto, and with our audited financial statements and notes thereto for the year ended December 31, 2021 found in the Form 10-K filed by Xperi Holding Corporation on February 24, 2022 (the “Form 10-K”).

This Quarterly Report contains forward-looking statements, which are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Words such as “expects,” “anticipates,” “plans,” “believes,” “seeks,” “estimates,” “could,” “would,” “may,” “intends,” “targets” and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this Quarterly Report. The identification of certain statements as “forward-looking” is not intended to mean that other statements not specifically identified are not forward-looking. All statements other than statements about historical facts are statements that could be deemed forward-looking statements, including, but not limited to, statements that relate to our future revenue, product development, demand, acceptance and market share, growth rate, competitiveness, gross margins, levels of research, development and other related costs, expenditures, the outcome or effects of and expenses related to litigation and administrative proceedings related to our patents, our intent to enforce our intellectual property rights, our ability to license our intellectual property, tax expenses, cash flows, our ability to liquidate and recover the carrying value of our investments, our management’s plans and objectives for our current and future operations, our plans for quarterly dividends and stock repurchases, the levels of customer spending or research and development activities, general economic conditions, the impact of the COVID-19 pandemic and related events, the impact of the Mergers (as defined below) and other acquisitions on our financial condition and results of operations, our plans to separate our product and IP licensing businesses, and the sufficiency of financial resources to support future operations and capital expenditures.

Although forward-looking statements in this Quarterly Report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks, uncertainties, and changes in condition, significance, value and effect, including those discussed under the heading “Risk Factors” in our annual report on Form 10-K and other documents we file from time to time with the Securities and Exchange Commission (the “SEC”), such as our quarterly reports on Form 10-Q and our current reports on Form 8-K. Such risks, uncertainties and changes in condition, significance, value and effect could cause our actual results to differ materially from those expressed herein and in ways not readily foreseeable. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report and are based on information currently and reasonably known to us. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Quarterly Report, other than as required by law. Readers are urged to carefully review and consider the various disclosures made in this Quarterly Report, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

Business Overview

 

On December 18, 2019, Xperi Corporation (“Xperi”) entered into a definitive agreement with TiVo Corporation (“TiVo”), to combine in an all-stock merger of equals transaction (the “Mergers”). Following consummation of the Mergers on June 1, 2020, Xperi Holding Corporation (“we”) became the parent company of both Xperi and TiVo.

 

We are a leading consumer and entertainment product/solutions licensing company and one of the industry’s largest intellectual property licensing platforms, with a diverse portfolio of media and semiconductor intellectual property and more than 11,000 patents and patent applications worldwide. We create extraordinary experiences at home and on the go for millions of consumers around the world, elevating content and how audiences connect with it in a way that is more intelligent, immersive and personal. Powering smart devices, connected cars, entertainment experiences and more, we have created a unified ecosystem that reaches highly engaged consumers, uncovering significant new business opportunities, now and in the future. Our technologies are integrated into billions of consumer devices, media platforms, and semiconductors worldwide, driving increased value for partners, customers and consumers. Headquartered in Silicon Valley with operations around the world, we have approximately 2,250 employees including the additions from the recent acquisition of Vewd Software Holdings Limited, and more than 35 years of operating experience.

We are currently planning, subject to any required regulatory approvals, a separation of our Product business and IP Licensing business through a tax-efficient transaction, resulting in two independent, publicly traded companies. We currently anticipate that the separation will be completed in the fall of 2022.

34


 

COVID-19 Impact

The COVID-19 pandemic has had, and may continue to have, an adverse impact on our business. The impact to date has included periods of significant volatility in markets we serve, in particular the automotive and broad consumer electronics markets. Additionally, the pandemic has caused some challenges and delays in acquiring new customers and executing license renewals. These factors have negatively impacted our financial condition and results of operations, and may result in an impairment of our long-lived assets, including goodwill, increased credit losses and impairments of investments in other companies.

Our operations and those of our customers have also been negatively impacted by certain trends arising from the COVID-19 pandemic, including labor market constraints, shortage of semiconductor components and manufacturing capacities, and delays in shipments, product development and product launches. Moreover, the COVID-19 pandemic, its related impact, and United States federal, state and foreign government policies enacted to combat the pandemic have contributed to a recent rise of inflation that may increase the cost of our operations and reduce demand for our products and services and those of our customers, which may adversely affect our financial performance.

Although a significant portion of our anticipated revenue for 2022 is derived from fixed-fee and minimum-guarantee arrangements, primarily from large, well-capitalized customers which we believe somewhat mitigates the risks to our business, our per-unit and variable-fee based revenue will continue to be susceptible to the volatility, labor shortages, supply chain disruptions, microchip shortages, and potential market downturns precipitated by the COVID-19 pandemic.

The impact of the pandemic on our overall results of operations remains uncertain for the foreseeable future. Further discussion of the potential impacts on our business from the COVID-19 pandemic is provided under Part I, Item 1A – Risk Factors of the Form 10-K.

Results of Operations

Revenue

 

We derive the majority of our revenue from the licensing of our technologies and intellectual property (“IP”) rights to customers. For our revenue recognition policy including descriptions of revenue-generating activities, refer to “Note 3 – Revenue” of the Notes to Condensed Consolidated Financial Statements.

The following table presents our historical operating results for the periods indicated as a percentage of revenue:

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Revenue:

 

 

100

%

 

 

100

%

 

 

100

%

 

 

100

%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue, excluding depreciation and amortization of intangible assets

 

 

12

 

 

 

12

 

 

 

11

 

 

 

13

 

Research, development and other related costs

 

 

27

 

 

 

25

 

 

 

25

 

 

 

25

 

Selling, general and administrative

 

 

31

 

 

 

30

 

 

 

29

 

 

 

30

 

Depreciation expense

 

 

2

 

 

 

3

 

 

 

2

 

 

 

3

 

Amortization expense

 

 

17

 

 

 

23

 

 

 

16

 

 

 

23

 

Litigation expense

 

 

1

 

 

 

1

 

 

 

1

 

 

 

1

 

Total operating expenses

 

 

90

 

 

 

94

 

 

 

84

 

 

 

95

 

Operating income

 

 

10

 

 

 

6

 

 

 

16

 

 

 

5

 

Interest expense

 

 

4

 

 

 

5

 

 

 

4

 

 

 

5

 

Other income (expense), net

 

 

 

 

 

(1

)

 

 

 

 

 

(1

)

Loss on debt extinguishment

 

 

 

 

 

4

 

 

 

 

 

 

2

 

Income before taxes

 

 

6

 

 

 

(2

)

 

 

12

 

 

 

(1

)

Provision for (benefit from) income taxes

 

 

9

 

 

 

(1

)

 

 

8

 

 

 

(2

)

Net income (loss)

 

 

(3

)%

 

 

(1

)%

 

 

4

%

 

 

1

%

 

35


 

 

Revenue (in thousands, except for percentages):

 

 

 

Three Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Revenue

 

$

234,018

 

 

$

222,272

 

 

$

11,746

 

 

 

5

%

 

The increase in revenue for the three months ended June 30, 2022, compared to the same period in the prior year, was primarily due to the settlement of a contract dispute with a large mobile imaging customer and the execution of a long-term license agreement with a leading consumer electronics and OTT service provider, for which a portion of the total revenue was recognized in the second quarter of 2022. The increase was partially offset by a decline in Product revenue from consumer hardware and legacy guides within the Pay TV market vertical and a one-time benefit to revenue in the second quarter of 2021 from a Stream 4K customer within the Media Platform market vertical.

 

 

 

Six Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Revenue

 

$

491,438

 

 

$

443,868

 

 

$

47,570

 

 

 

11

%

 

The increase in revenue for the six months ended June 30, 2022, compared to the same period in the prior year, was primarily due to the execution of a new, multi-year license agreement with a large semiconductor company, the settlement of a contract dispute with a large mobile imaging customer, and the execution of a long-term license agreement with a leading consumer electronics and OTT service provider, for which a portion of the total revenue was recognized in the first two quarters of 2022. The increase was partially offset by a decline in Product revenue driven largely by a decrease in revenue from consumer hardware and legacy guides within the Pay TV market vertical, one-time recovery of royalties from a customer in 2021 within Consumer Electronics market vertical, and one-time benefit to revenue in the second quarter of 2021 from a Stream 4K customer within the Media Platform market vertical.

Cost of Revenue, Excluding Depreciation and Amortization of Intangible Assets

Cost of revenue, excluding depreciation and amortization of intangible assets, consists primarily of employee-related costs, royalties paid to third parties, hardware product-related costs, maintenance costs and an allocation of facilities costs, as well as service center and other expenses related to providing our technology solution offerings and NRE services.

 

 

 

Three Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Cost of revenue, excluding depreciation and amortization of intangible assets

 

$

27,074

 

 

$

26,884

 

 

$

190

 

 

 

1

%

 

Cost of revenue, excluding depreciation and amortization of intangible assets is relatively flat for the three months ended June 30, 2022, compared to the same period in the prior year.

 

 

 

Six Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Cost of revenue, excluding depreciation and amortization of intangible assets

 

$

54,771

 

 

$

55,014

 

 

$

(243

)

 

 

(0

)%

 

Cost of revenue, excluding depreciation and amortization of intangible assets is relatively flat for the six months ended June 30, 2022, compared to the same period in the prior year.

 

36


 

Research, Development and Other Related Costs

Research, development and other related costs (“R&D expense”) are comprised primarily of employee-related costs, stock-based compensation expense, engineering consulting expenses associated with new product and technology development, product commercialization, quality assurance and testing costs, as well as costs related to patent applications and examinations, reverse engineering, materials, supplies, and an allocation of facilities costs. All research, development and other related costs are expensed as incurred.

 

 

 

Three Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Research, development and other related costs

 

$

62,145

 

 

$

54,408

 

 

$

7,737

 

 

 

14

%

The increase in R&D expense for the three months ended June 30, 2022, compared to the same period in the prior year, was primarily driven by higher personnel costs and increased bonus expense driven by expected higher bonus percentage attainment. The increase in personnel costs was primarily driven by employees hired in connection with the acquisition of certain assets of MobiTV ("the MobiTV Acquisition") in May 2021.

 

 

 

Six Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Research, development and other related costs

 

$

121,515

 

 

$

109,603

 

 

$

11,912

 

 

 

11

%

The increase in R&D expense for the six months ended June 30, 2022, compared to the same period in the prior year, was primarily driven by higher personnel costs and increased bonus expense driven by expected higher bonus percentage attainment, partially offset by reductions in outside service and contractors expenditure in the first two quarters of 2022. The increase in personnel costs was primarily driven by employees hired in connection with the MobiTV Acquisition in May 2021.

We believe that a significant level of R&D expense will be required for us to remain competitive in the future. We also expect R&D expense to increase in future periods as a result of the Vewd acquisition which closed on July 1, 2022.

Selling, General and Administrative

Selling expenses consist primarily of compensation and related costs for sales and marketing personnel engaged in sales and licensee support, reverse engineering personnel and services, marketing programs, public relations, promotional materials, travel, trade show expenses, and stock-based compensation expense. General and administrative expenses consist primarily of compensation and related costs for general management, information technology, finance personnel, legal fees and expenses, facilities costs, stock-based compensation expense, and professional services. Our general and administrative expenses, other than facilities-related expenses, are not allocated to other expense line items.

 

 

 

Three Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Selling, general and administrative

 

$

72,116

 

 

$

67,668

 

 

$

4,448

 

 

 

7

%

The increase in selling, general, and administrative ("SG&A") expenses for the three months ended June 30, 2022, compared to the same period in the prior year, was primarily due to increased bonus expense driven by expected higher bonus percentage attainment and increased transaction costs related to the Vewd acquisition that closed subsequent to the second quarter of 2022, partially offset by a decrease in banker fees driven by the refinancing of debt that was completed in the second quarter of 2021.

 

37


 

 

 

Six Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Selling, general and administrative

 

$

121,515

 

 

$

109,603

 

 

$

11,912

 

 

 

11

%

The increase in SG&A expenses for the six months ended June 30, 2022, compared to the same period in the prior year, was primarily due to incremental stock-based compensation recognized in connection with the accelerated vesting of outstanding restricted stock units upon the separation of a former executive in the first quarter of 2022, an increase in costs related to planned business separation, increase in bonus expense driven by expected higher percentage attainment, partially offset by a reductions in the provision for credit losses and banker fees.

Depreciation Expense

 

 

 

Three Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Depreciation expense

 

$

5,505

 

 

$

5,514

 

 

$

(9

)

 

 

(0

)%

Depreciation expense for the three months ended June 30, 2022 is relatively flat compared to the same period in the prior year.

 

 

 

Six Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Depreciation expense

 

$

11,371

 

 

$

11,198

 

 

$

173

 

 

 

2

%

Depreciation expense for the six months ended June 30, 2022 is relatively flat compared to the same period in the prior year.

Amortization Expense

 

 

 

Three Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Amortization expense

 

$

39,166

 

 

$

52,242

 

 

$

(13,076

)

 

 

(25

)%

The decrease in amortization expense for the three months ended June 30, 2022, compared to the same period in the prior year, was primarily due to certain acquired intangible assets becoming fully amortized in late 2021 causing a decrease in the quarterly amortization expense in 2022 when compared to the same period in the prior year.

 

 

 

Six Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Amortization expense

 

$

78,485

 

 

$

104,437

 

 

$

(25,952

)

 

 

(25

)%

The decrease in amortization expense for the six months ended June 30, 2022, compared to the same period in the prior year, was primarily due to certain acquired intangible assets becoming fully amortized in late 2021 causing a decrease in the quarterly amortization expense in 2022 when compared to the same period in the prior year.

38


 

Litigation Expense

 

 

 

Three Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Litigation expense

 

$

3,161

 

 

$

2,302

 

 

$

859

 

 

 

37

%

The increase in litigation expense for the three months ended June 30, 2022, compared to the same period in the prior year, was primarily due to a $2.2 million reserve recorded for estimated expense reimbursement due to Videotron as a result of the outcome of that litigation matter, partially offset by reduced case activity.

 

 

 

Six Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Litigation expense

 

$

4,914

 

 

$

4,835

 

 

$

79

 

 

 

2

%

The increase in litigation expense for the six months ended June 30, 2022, compared to the same period in the prior year, was primarily due to the previously mentioned $2.2 million reserve related to the Videotron matter, partially offset by reduced case activity.

We expect that litigation expense will continue to be a material portion of our operating expenses. Litigation expense may fluctuate between periods because of planned or ongoing litigation, as described in Part II, Item 1 – Legal Proceedings, and because of litigation planned for or initiated from time to time in the future in order to enforce and protect our intellectual property and contract rights.

Upon expiration of our customers’ licenses, if those licenses are not renewed, litigation may become necessary to secure payment of reasonable royalties for the use of our patented technology. If we plan for or initiate such litigation, our future litigation expenses may increase.

Stock-based Compensation Expense

The following table sets forth our stock-based compensation (“SBC”) expense for the three and six months ended June 30, 2022 and 2021 (in thousands):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Cost of revenue, excluding depreciation and amortization of intangible assets

 

$

773

 

 

$

529

 

 

$

1,401

 

 

$

852

 

Research, development and other related costs

 

 

6,074

 

 

 

4,810

 

 

 

11,548

 

 

 

9,157

 

Selling, general and administrative

 

 

8,634

 

 

 

9,496

 

 

 

19,335

 

 

 

18,045

 

Total stock-based compensation expense

 

$

15,481

 

 

$

14,835

 

 

$

32,284

 

 

$

28,054

 

 

Stock-based compensation awards include employee stock options, restricted stock awards and units, and employee stock plan purchases. The increase in SBC expense for the three months ended June 30, 2022, compared to the corresponding period in 2021, was primarily due to the increase in stock award grants made in 2021 resulting from the MobiTV Acquisition. The increase in SBC expense for the six months ended June 30, 2022, compared to the corresponding period in 2021, was primarily a result of the accelerated vesting of outstanding restricted stock units upon the separation of a former executive, and secondarily from the increase in stock award grants made in 2021 resulting from the Mergers and the MobiTV Acquisition.

39


 

Interest Expense

 

 

 

Three Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Interest expense

 

$

9,440

 

 

$

10,555

 

 

$

(1,115

)

 

 

(11

)%

The decrease in interest expense for the three months ended June 30, 2022, compared to the same period in the prior year, was primarily due to a lower average debt balance as compared to the same period in 2021 as we continue to pay down principal balance during the intervening period, and secondly to a reduction in interest rate as a result of the debt refinancing in June 2021.

 

 

 

Six Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Interest expense

 

$

17,868

 

 

$

21,868

 

 

$

(4,000

)

 

 

(18

)%

The decrease in interest expense for the six months ended June 30, 2022, compared to the same period in the prior year, was primarily due to a lower average debt balance as compared to the same period in 2021 as we continue to pay down principal balance during the intervening period, and secondly to a reduction in interest rate as a result of the debt financing in June 2021.

We anticipate interest expense will decrease in 2022 when compared to 2021 as a result of a full year of the lower debt balance and amortization of debt discount and issuance costs. However, those reductions are expected to be partially offset by increasing interest rates since the interest rate on our existing debt is variable. In addition, we will incur additional interest expense as a result of $50.0 million debt assumed under the Vewd Acquisition which closed on July 1, 2022.

Other Income and Expense, Net

 

 

 

Three Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Other income, net

 

$

254

 

 

$

564

 

 

$

(310

)

 

 

(55

)%

Other income, net for the three months ended June 30, 2022 is relatively flat compared to the same period in the prior year.

 

 

 

Six Months Ended
June 30,

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

Increase/ (Decrease)

 

 

% Change

 

Other income, net

 

$

1,221

 

 

$

1,989

 

 

$

(768

)

 

 

(39

)%

The decrease in other income, net for the six months ended June 30, 2022, compared to the same period in the prior year, was primarily driven by decrease in realized loss on investment and other miscellaneous income in the 2022 period, partially offset by an increase interest income due to the execution of a multi-year license agreement with a large semiconductor customer in the first quarter of 2021.

 

40


 

Loss on Debt Extinguishment
 

In June 2021, we refinanced the 2020 Term B Loan Facility by, among other things, lowering the interest rate on the debt. Certain lenders of the original loan syndication did not participate in the refinancing. Accordingly, we accounted for the refinancing event for these lenders as a debt extinguishment and recorded, in the second quarter of 2021, a loss on debt extinguishment of $8.0 million related to the write-off of unamortized debt discount and issuance costs for the portions of the 2020 Term B Loan Facility considered to be extinguished.
 

Provision for Income Taxes

Our provision for income taxes is based on our worldwide estimated annualized effective tax rate. For jurisdictions in which a loss is forecast but no benefit can be realized for those losses, the tax is estimated separately. In certain circumstances we also record the income tax effects of discrete transactions in the quarter in which the transaction has occurred. Foreign withholding taxes, U.S. federal and state income taxes, and unrealized foreign exchange loss from the prior South Korea refund claims are the primary drivers of income tax expense and the primary reasons for cash tax payments of income taxes. For the three and six months ended June 30, 2022, our effective tax rate varies significantly from the 21% U.S. federal tax rate due to foreign withholding taxes, state income taxes, and unrealized foreign exchange loss from prior South Korea refund claims.

For the three months ended June 30, 2022, we recorded an income tax expense of $22.1 million on pretax income of $15.7 million, and for the six months ended June 30, 2022 we recorded an income tax expense of $43.7 million on pretax income of $61.2 million, which resulted in an effective tax rate of 71.4% for the six months ended June 30, 2022. The income tax expense for the three and six months ended June 30, 2022 was primarily related to foreign withholding taxes, U.S. federal income tax, state income taxes, and unrealized foreign exchange loss from the prior South Korea refund claims.

For the three months ended June 30, 2021, we recorded an income tax benefit of $2.9 million on pretax loss of $4.7 million, and for the six months ended June 30, 2021, we recorded an income tax benefit of $6.9 million on pretax loss of $4.2 million, which resulted in an effective tax rate of 162.6% for the six months ended June 30, 2021. The income tax benefit for the three and six months ended June 30, 2021 was primarily related to projected negative U.S. effective tax rate applied to a year-to-date U.S. profit before tax.

The year-over-year increase in income tax expense for the quarter ended June 30, 2022 is largely attributable to the application of a negative effective tax rate to the June 30, 2021 year-to-date U.S. pre-tax income.

The need for a valuation allowance requires an assessment of both positive and negative evidence when determining whether it is more-likely-than-not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction-by-jurisdiction basis. In making such assessment, significant weight is given to evidence that can be objectively verified. After considering both positive and negative evidence to assess the recoverability of our net deferred tax assets, we determined that it was not more-likely-than-not that we would realize our federal, certain state and certain foreign deferred tax assets given the substantial amount of tax attributes that will remain unutilized to offset forecasted future tax liabilities. In the future, we may release our deferred tax asset valuation allowance associated with our federal, state or foreign deferred tax assets depending on achievement of future profitability in relevant jurisdictions or the implementation of tax planning strategies that enable us to utilize deferred tax assets. There can be no assurance that we will generate profits or implement tax strategies in future periods enabling us to fully realize our deferred tax assets. The timing of recording a deferred tax asset valuation allowance or the reversal of such valuation allowance is subject to objective and subjective factors that cannot be known in advance. We intend to continue maintaining a full valuation allowance on our federal deferred tax assets until there is sufficient evidence to support the reversal of all or a portion of these allowances. However, given our current earning and anticipated future earnings, we believe that there is a reasonable possibility that within the next 12 months, sufficient positive evidence may become available to allow us to reach a conclusion that a significant portion of our federal valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain federal deferred tax assets and a decrease to income tax expense for the period the release is recorded.

 

41


 

Segment Operating Results

We operate in two reportable segments: (1) IP Licensing and (2) Product. There are certain corporate overhead costs that are not allocated to these reportable segments because these operating amounts are not considered in evaluating the operating performance of our business segments.

Our Chief Executive Officer has been determined to be the Chief Operating Decision Maker (“CODM”) in consideration with the authoritative guidance on segment reporting.

In our IP Licensing segment, we primarily license our innovations to leading companies in the broader entertainment and semiconductor industries, and those developing new technologies that will help drive the industries forward. Licensing arrangements include access to one or more of our foundational patent portfolios and may also include access to some of our industry-leading technologies and proven know-how. In our Product segment, we derive the majority of the revenue from licensing our technology to customers primarily through Technology License arrangements and Technology Solutions arrangements. For Technology License arrangements, the customer obtains rights to the technology delivered at the commencement of the agreement. For Technology Solutions arrangements, the customer receives access to a platform, media or data that includes frequent updates, where access to such updates is critical to the functionality of the technology.

We do not identify or allocate assets by reportable segment, nor does the CODM evaluate reportable segments using discrete asset information. Reportable segments do not record inter-segment revenue and accordingly there are none to report. Although the CODM uses operating income to evaluate reportable segments, operating costs included in one segment may benefit other segments.

The following table sets forth our segments’ revenue, operating expenses and operating income (in thousands):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

IP Licensing segment

 

$

107,815

 

 

$

101,846

 

 

$

246,346

 

 

$

199,860

 

Product segment

 

 

126,203

 

 

 

120,426

 

 

 

245,092

 

 

 

244,008

 

Total revenue

 

 

234,018

 

 

 

222,272

 

 

 

491,438

 

 

 

443,868

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

IP Licensing segment

 

 

38,474

 

 

 

34,875

 

 

 

73,766

 

 

 

68,442

 

Product segment

 

 

97,404

 

 

 

105,047

 

 

 

194,915

 

 

 

213,579

 

Unallocated operating expenses

 

 

73,289

 

 

 

69,096

 

 

 

144,937

 

 

 

138,194

 

Total operating expenses

 

 

209,167

 

 

 

209,018

 

 

 

413,618

 

 

 

420,215

 

Operating income:

 

 

 

 

 

 

 

 

 

 

 

 

IP Licensing segment

 

 

69,341

 

 

 

66,971

 

 

 

172,580

 

 

 

131,418

 

Product segment

 

 

28,799

 

 

 

15,379

 

 

 

50,177

 

 

 

30,429

 

Unallocated operating expenses

 

 

(73,289

)

 

 

(69,096

)

 

 

(144,937

)

 

 

(138,194

)

Total operating income

 

$

24,851

 

 

$

13,254

 

 

$

77,820

 

 

$

23,653

 

 

For the three months ended June 30, 2022, the unallocated operating expenses were $73.3 million, compared to $69.1 million for the three months ended June 30, 2021. The increase of $4.2 million was due principally to incremental bonus expense as a result of expected higher bonus percentage attainment and increased transaction costs related to the Vewd Acquisition that closed subsequent to the second quarter of 2022, partially offset by a decrease in banker fees as a result of the refinancing of debt that was completed in the second quarter of 2021.

For the six months ended June 30, 2022, the unallocated operating expenses were $144.9 million compared to $138.2 million for the six months ended June 30, 2021. The increase of $6.7 million is primarily due to incremental stock-based compensation recognized in connection with the accelerated vesting of outstanding restricted stock units upon the separation of a former executive in the first quarter of 2022, an increase in costs related to planned business separation, and increase in bonus expense driven by expected higher bonus percentage attainment, partially offset by a reduction in the provision for credit losses, and reduced banker fees.

The revenue and operating income amounts in this section have been presented on a basis consistent with GAAP applied at the segment level. As of June 30, 2022, we had a total of $850.1 million in goodwill, approximately $322.3 million of which was allocated to our IP Licensing segment and approximately $527.8 million of which was allocated to our Product segment.

42


 

IP Licensing Segment

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Revenue

 

$

107,815

 

 

$

101,846

 

 

$

246,346

 

 

$

199,860

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue, excluding depreciation and amortization of intangible assets

 

 

194

 

 

 

400

 

 

 

485

 

 

 

547

 

Research, development and other related costs

 

 

10,759

 

 

 

7,983

 

 

 

19,914

 

 

 

15,208

 

Litigation

 

 

2,843

 

 

 

1,738

 

 

 

3,921

 

 

 

3,181

 

Depreciation

 

 

272

 

 

 

254

 

 

 

514

 

 

 

506

 

Amortization

 

 

24,406

 

 

 

24,500

 

 

 

48,932

 

 

 

49,000

 

Total operating expenses

 

 

38,474

 

 

 

34,875

 

 

 

73,766

 

 

 

68,442

 

Total operating income

 

$

69,341

 

 

$

66,971

 

 

$

172,580

 

 

$

131,418

 

IP Licensing revenue for the three months ended June 30, 2022 was $107.8 million as compared to $101.8 million for the three months ended June 30, 2021, an increase of $6.0 million. The increase was primarily attributable to the execution of a long-term license agreement with a leading consumer electronics and OTT service provider for which a meaningful portion of the total revenue was recognized in the quarter, partially offset by a decline in revenue from Media IP licensing business due to past royalty revenue recorded in the second quarter of 2021.

IP Licensing revenue for the six months ended June 30, 2022 was $246.4 million as compared to $199.9 million for the six months ended June 30, 2021, an increase of $46.5 million. The increase was primarily attributable to a new, multi-year license agreement with a large semiconductor customer and a new, long-term license agreement with a leading consumer electronics and OTT service provider for which a meaningful portion of the total revenue was recognized in the first six months of 2022.

Operating expenses for the three months ended June 30, 2022 were $38.5 million, as compared to $34.9 million for the three months ended June 30, 2021, an increase of $3.6 million. The increase was primarily due to an increase in R&D costs due to increased headcount and personnel costs as well as investments in both Media and Semiconductor technology and an increase in litigation expense.

Operating expenses for the six months ended June 30, 2022 were $73.8 million, as compared to $68.4 million for the six months ended June 30, 2021, an increase of $5.4 million. The increase was primarily due to an increase in R&D costs due to increased headcount and personnel costs as well as investments in both Media and Semiconductor technology.

Litigation expenses for the three months ended June 30, 2022, were $2.8 million, as compared to $1.7 million for the three months ended June 30, 2021, an increase of $1.1 million. The increase was primarily due to a $2.2 million reserve recorded for estimated expense reimbursement due to Videotron as a result of the outcome of that litigation matter, partially offset by reduced case activity.

Litigation expenses for the six months ended June 30, 2022, were $3.9 million, as compared to $3.2 million for the six months ended June 30, 2021, an increase of $0.7 million. The increase was primarily due to the reasons stated above.
 

We expect that litigation expense will continue to be a material portion of our operating expenses and may fluctuate between periods because of planned or ongoing litigation, as described in Part II, Item 1 – Legal Proceedings, in this report, and because of litigation planned for or initiated from time to time in the future in order to enforce and protect our intellectual property and contract rights.

Operating income for the three months ended June 30, 2022 was $69.3 million, as compared to $67.0 million for the three months ended June 30, 2021, an increase of $2.4 million. The increase was primarily due to reasons stated above, including the execution of a long-term IP license agreement with a leading consumer electronics and OTT service provider.

Operating income for the six months ended June 30, 2022 was $172.6 million, as compared to $131.4 million for the six months ended June 30, 2021, an increase of $41.2 million. The increase was primarily due to reasons stated above, including the execution of a multi-year IP license agreement with a large semiconductor customer and a long-term IP license agreement with a leading consumer electronics and OTT service provider.

 

43


 

Product Segment

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Revenue

 

$

126,203

 

 

$

120,426

 

 

$

245,092

 

 

$

244,008

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue, excluding depreciation and amortization of intangible assets

 

 

26,879

 

 

 

26,484

 

 

 

54,285

 

 

 

54,467

 

Research, development and other related costs

 

 

51,368

 

 

 

46,425

 

 

 

101,583

 

 

 

94,395

 

Litigation

 

 

319

 

 

 

564

 

 

 

994

 

 

 

1,654

 

Depreciation

 

 

4,078

 

 

 

3,832

 

 

 

8,500

 

 

 

7,626

 

Amortization

 

 

14,760

 

 

 

27,742

 

 

 

29,553

 

 

 

55,437

 

Total operating expenses

 

 

97,404

 

 

 

105,047

 

 

 

194,915

 

 

 

213,579

 

Total operating income

 

$

28,799

 

 

$

15,379

 

 

$

50,177

 

 

$

30,429

 

Product revenue for the three months ended June 30, 2022 was $126.2 million as compared to $120.4 million for the three months ended June 30, 2021, an increase of $5.8 million. The increase was primarily attributable to the settlement of a contract dispute with a large mobile imaging customer partially offset by a decrease in revenue from consumer hardware and legacy guides within the Pay TV market vertical and a one-time benefit to revenue in the second quarter of 2021 from a Stream 4K customer within the Media Platform market vertical.

Product revenue for the six months ended June 30, 2022 was $245.1 million as compared to $244.0 million for the six months ended June 30, 2021, an increase of $1.1 million. The increase was primarily attributable to increased revenue from the settlement of a contract dispute with a large mobile imagining customer partially offset by significant settlement of past royalties from a customer in the first quarter of 2021, and to continued supply chain constraints that impacted our customers’ shipment volumes in our Connected Car and Consumer Electronics businesses.

Operating expenses for the three months ended June 30, 2022 were $97.4 million, as compared to $105.0 million for the three months ended June 30, 2021, a decrease of $7.6 million. The decrease was primarily due to lower amortization expense, partially offset by an increase in R&D cost primarily due to employees hired in connection with the MobiTV Acquisition in May 2021. The lower amortization was attributable to certain intangible assets becoming fully amortized in the fourth quarter of 2021.

Operating expenses for the six months ended June 30, 2022 were $194.9 million, as compared to $213.6 million for the six months ended June 30, 2021, a decrease of $18.7 million. The decrease was primarily driven by lower amortization expense, partially offset by an increase in R&D cost primarily due to employees hired in connection with the MobiTV Acquisition in May 2021. The lower amortization was attributable to certain intangible assets becoming fully amortized in the fourth quarter of 2021.

Operating income for the three months ended June 30, 2022 was $28.8 million, as compared to $15.4 million for the three months ended June 30, 2021, an increase of $13.4 million. The increase was primarily due to reasons stated above.

Operating income for the six months ended June 30, 2022 was $50.2 million, as compared to $30.4 million for the six months ended June 30, 2021, an increase of $19.7 million. The increase was primarily due to reasons stated above.

Liquidity and Capital Resources

 

The following table presents selected financial information related to our liquidity and significant sources and uses of cash and cash equivalents as of and for the periods presented.

 

 

 

As of

 

(in thousands, except for percentages)

 

June 30, 2022

 

 

December 31, 2021

 

Cash and cash equivalents

 

$

275,319

 

 

$

201,121

 

Short-term investments

 

 

10,495

 

 

 

60,534

 

Total cash, cash equivalents and short-term investments

 

$

285,814

 

 

$

261,655

 

Percentage of total assets

 

 

12

%

 

 

11

%

 

44


 

 

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

Net cash from operating activities

 

$

87,033

 

 

$

82,979

 

Net cash from investing activities

 

$

40,800

 

 

$

(6,215

)

Net cash from financing activities

 

$

(51,344

)

 

$

(117,184

)

Our primary sources of liquidity and capital resources are our operating cash flows and our short-term investments. Cash, cash equivalents and short-term investments were $285.8 million at June 30, 2022, an increase of $24.2 million from $261.7 million at December 31, 2021. This increase resulted primarily from $87.0 million in cash generated from operations, $28.3 million in proceeds from sales of investments $26.1 million in proceeds from maturities of investments and $8.1 million in proceeds from the issuance of common stock under our employee stock grant programs and employee stock purchase plans, which was partially offset by $10.4 million in dividends paid, $28.7 million in repurchases of common stock, $20.3 million in repayment of long-term debt, and $8.9 million of capital expenditures. Cash and cash equivalents totaled $275.3 million at June 30, 2022, an increase of $74.2 million from $201.1 million at December 31, 2021.

On July 1, 2022, the Company closed the Vewd Acquisition for total consideration of approximately $109 million, consisting of approximately $59 million of cash and $50 million of debt. The term of the debt is 3 years and the interest rate is fixed at 6%.

The primary objectives of our investment activities are to preserve principal and to maintain liquidity while at the same time capturing a market rate of return. To achieve these objectives, we maintain a diversified portfolio of securities including money market funds and debt securities including corporate bonds and notes, municipal bonds and notes, commercial paper, treasury and agency notes and bills and certificates of deposit. We invest excess cash predominantly in high-quality investment grade debt securities with less than three years to maturity. Our marketable debt securities are classified as available-for-sale (“AFS”) with credit losses recognized as a credit loss expense and non-credit related unrealized gains and losses, net of tax, recorded in accumulated other comprehensive income or loss.

For information about our material cash requirements, see “Liquidity and Capital Resources” in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2021. Other than the principal payment of $20.3 million made by us under the Refinanced Term B Loans during the six months ended June 30, 2022, our cash requirements have not changed materially since December 31, 2021.

In addition to our cash requirements, we have returned cash to stockholders through both quarterly dividend payments and repurchases of our common stock under our stock repurchase plan.

Quarterly Dividends

 

In July 2022, our Board of Directors authorized payment of a quarterly dividend of $0.05 per share, to be paid in September 2022. We anticipate that all quarterly dividends will be paid out of cash, cash equivalents and short-term investments.

 

Stock Repurchase Plan

 

On June 12, 2020, our Board of Directors terminated a prior stock repurchase program and approved a new stock repurchase plan (the “Plan”) providing for the repurchase of up to $150.0 million of our common stock dependent on market conditions, share price and other factors. No expiration has been specified for this Plan. On April 22, 2021, our Board of Directors authorized an additional $100.0 million of purchases under the Plan. The stock repurchases may be made from time to time, through solicited or unsolicited transactions in the open market, in privately negotiated transactions, or pursuant to a Rule 10b5-1 plan. Since the inception of the Plan, and through June 30, 2022, we have repurchased an aggregate of approximately 10.0 million shares of common stock at a total cost of $172.2 million at an average price of $17.24. During the three months ended March 31, 2022, we repurchased an aggregate of approximately 1.0 million shares of common stock at a total cost of $17.3 million at an average price of $16.78. We did not repurchase any stock during the three months ended June 30, 2022. As of June 30, 2022, the total remaining amount available for repurchase under the Plan was $77.8 million. We may continue to execute authorized repurchases from time to time under the Plan. The amount and timing of any repurchases under the Plan depend on a number of factors, including but not limited to, the trading price, volume and availability of our common shares. In addition, as we plan for the separation of our Product business and IP Licensing business we may reduce or suspend share repurchases as we plan for the capital needs of two independent businesses. There is no guarantee that such repurchases under the Plan will enhance the value of our common stock.

 

45


 

From 2020 through the second quarter of 2022, we generated approximately $796 million of cash flows from operating activities. While we expect to continue to generate cash flows from operating activities in 2022, the COVID-19 pandemic continues to present uncertainties as to the level of such cash flows as compared to prior years. Additionally, transaction costs relating to the planned separation of our two business segments are expected to impact operating cash flows for at least the next 6 months. We have taken actions to manage cash flows by reducing discretionary spending and other variable costs, and closely monitoring receivables and payables.

 

We believe that based on current levels of operations and anticipated growth, our cash from operations, together with cash, cash equivalents and investments currently available, will be sufficient to satisfy our currently anticipated cash requirements through at least the next twelve (12) months and thereafter for the foreseeable future. Poor financial results, unanticipated expenses, unanticipated acquisitions of technologies or businesses, or unanticipated strategic investments could give rise to additional financing requirements sooner than we expect. There can be no assurance that equity or debt financing will be available when needed or, if available, that such financing will be on terms satisfactory to us. The sale of additional equity securities could result in dilution to our stockholders. The incurrence of indebtedness would result in increased debt service obligations and may include covenants that would restrict our operations.

 

Cash Flows from Operating Activities

Cash flows provided by operations were $87.0 million for the six months ended June 30, 2022, primarily due to our net income of $17.5 million being further adjusted for non-cash items of depreciation of $11.4 million, amortization of intangible assets of $78.5 million and stock-based compensation expense of $32.3 million. These increases were partially offset by $54.1 million in changes in operating assets and liabilities including payment during the first quarter of employee bonuses earned in 2021.

Cash flows provided by operations were $83.0 million for the six months ended June 30, 2021, primarily due to our net income of $2.7 million being further adjusted for non-cash items of depreciation of $11.2 million, amortization of intangible assets of $104.4 million, stock-based compensation expense of $28.1 million and a loss on debt extinguishment of $8.0 million. These increases were partially offset by $77.9 million in changes in operating assets and liabilities including payments of employee annual bonuses earned in 2020.

 

Cash Flows from Investing Activities

Net cash provided by investing activities was $40.8 million for the six months ended June 30, 2022, primarily related to maturities and sales of securities of $54.3 million, partially offset by purchases of short-term investments of $4.5 million and capital expenditures of $8.9 million. The sales of securities included activity in late June in anticipation of the Vewd Acquisition which closed on July 1, 2022.

Net cash used in investing activities was $6.2 million for the six months ended June 30, 2021, primarily related to purchases of short-term investments of $45.8 million, cash used in the MobiTV Acquisition of $17.4 million and capital expenditures of $4.9 million, partially offset by maturities and sales of securities of $61.9 million.

Capital Expenditures

Our capital expenditures for property, plant, and equipment consist primarily of purchases of computer hardware and software, information systems, production and test equipment. During the six months ended June 30, 2022 and 2021, we spent $8.9 million and $4.9 million on capital expenditures, respectively, and we expect capital expenditures in 2022 to be between $20.0 million to $25.0 million. These expenditures are expected to be financed with cash from operations, existing cash and cash equivalents, and short-term investments. There can be no assurance that current expectations will be realized and plans are subject to change upon further review of our capital expenditure needs.

Cash Flows from Financing Activities

Net cash used in financing activities was $51.3 million for the six months ended June 30, 2022 principally due to $20.3 million in repayment of indebtedness, $10.4 million in dividends paid, and $28.7 million in repurchases of common stock, partially offset by $8.1 million in proceeds due to the issuance of common stock under our employee stock grant programs and employee stock purchase plans.

Net cash used in financing activities was $117.2 million for the six months ended June 30, 2021 principally due to $63.8 million in repayment of indebtedness, $6.8 million in debt refinancing costs, $10.5 million in dividends paid, and $43.3 million in repurchases of common stock, partially offset by $7.2 million in proceeds from the issuance of common stock under our employee stock grant programs and employee stock purchase plans.

46


 

 

Long-term Debt

On June 8, 2021, we amended that certain Credit Agreement dated June 1, 2020 by and among us, the lenders party thereto and Bank of America, N.A., as administrative agent and collateral agent (the “2020 Credit Agreement”). The 2020 Credit Agreement initially provided for a five-year senior secured term B loan facility in an aggregate principal amount of $1,050 million (the “2020 Term B Loan Facility”). In connection with the amendment (the “Amendment”), we made a voluntary prepayment of $50.6 million of the term loan outstanding under the 2020 Credit Agreement using cash on hand. The Amendment provided for, among other things, (i) a new tranche of term loans (the “Refinanced Term B Loans”) in an aggregate principal amount of $810.0 million, (ii) a reduction of the interest rate margin applicable to such loans to (x) in the case of base rate loans, 2.50% per annum and (y) in the case of Eurodollar loans, LIBOR plus a margin of 3.50% per annum, (iii) a prepayment premium of 1.00% in connection with any repricing transaction with respect to the Refinanced Term B Loans within six months of the closing date of the Amendment, (iv) an extension of the maturity to June 8, 2028, and (v) certain additional amendments, including amendments to provide us with additional flexibility under the covenant governing restricted payments. We commenced repaying quarterly installments under the Refinanced Term B Loans in the third quarter of 2021.

At June 30, 2022, $769.5 million was outstanding under the Refinanced Term B Loans with an interest rate, including amortization of debt discount and issuance costs, of 4.56%. Interest is payable monthly. Under the existing loan agreements, we have future minimum principal payments for our debt of $20.3 million for the remainder of 2022, $40.5 million in each year from 2023 through 2027, with the remaining principal balance of $546.8 million due in 2028. We are obligated to pay a portion of excess cash flow on an annual basis beginning in March 2023 based on certain leverage ratios and our excess cash flow generated for the immediately preceding calendar year. The Refinanced Term B Loans contain customary covenants, and as of June 30, 2022, we were in full compliance with such covenants.

Critical Accounting Policies and Estimates

During the three and six months ended June 30, 2022, there were no significant changes in our critical accounting policies and estimates. See “Note 2 – Summary of Significant Accounting Policies” of Notes to the Condensed Consolidated Financial Statements for additional detail. For a discussion of our critical accounting policies and estimates, see Part II, Item 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Form 10-K.

Recent Accounting Pronouncements

See “Note 2 – Summary of Significant Accounting Policies” of the Notes to Condensed Consolidated Financial Statements for a full description of recent accounting pronouncements including the respective expected dates of adoption.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

For a discussion of our market risk, see Part II, Item 7A – Quantitative and Qualitative Disclosures About Market Risk in the Form 10-K.

Item 4. Controls and Procedures

Attached as exhibits to this Form 10-Q are certifications of Xperi Holding Corporation’s Chief Executive Officer and Chief Financial Officer, which are required in accordance with Rule 13a-14 of the Exchange Act. This “Controls and Procedures” section includes information concerning the controls and controls evaluation referred to in the certifications and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

Evaluation of Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted pursuant to the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

47


 

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this report (the evaluation date). Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded as of the evaluation date that our disclosure controls and procedures were effective to provide reasonable assurance that the information relating to Xperi Holding Corporation, including our consolidated subsidiaries, required to be disclosed in our SEC reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to Xperi Holding Corporation’s management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act, during the last fiscal quarter covered by this Quarterly Report on Form 10-Q that materially affected or are reasonably likely to materially affect our internal control over financial reporting.

 

48


 

PART II - OTHER INFORMATION

In the normal course of our business, we are involved in legal proceedings. In the past, we have litigated to enforce our patents and other intellectual property rights, to enforce the terms of license agreements, to protect trade secrets, to determine the validity and scope of the proprietary rights of others and to defend ourselves or our customers against claims of infringement or invalidity. We expect to continue to be involved in similar legal proceedings in the future, including proceedings regarding infringement of our patents and proceedings to ensure proper and full payment of royalties by licensees under the terms of our license agreements.

Other than to the extent the proceedings described below have concluded, we cannot predict the outcome of any of the proceedings described below. An adverse decision in any of these proceedings could significantly harm our business and our consolidated financial position, results of operations, and cash flows.

Patent Infringement Litigation

From time-to-time in the ordinary course of our IP licensing business, we are required to engage in litigation to protect our intellectual property from infringement. While litigation is never our preference and we prefer to reach mutually agreeable commercial licensing arrangements with third parties, it is sometimes a necessary step to effectively protect our investment in patented technology. As a result of these lawsuits, defendants have often filed Inter Partes Review (“IPR”) petitions with the U.S. Patent Office’s Patent Trial and Appeal Board (and other similar post-grant proceedings outside of the U.S.) seeking to invalidate one or more of the patents-in-suit. We are currently engaged in multiple lawsuits with several third parties.

Videotron Patent Infringement Litigation

On June 23, 2017, Rovi Guides, Inc. and TiVo Solutions Inc. (together, “TiVo”) filed a patent infringement complaint against Videotron Ltd. and Videotron G.P. (together, “Videotron”) in Toronto, Canada, alleging infringement of six patents (“Videotron 1”). Videotron was a prior licensee under the Rovi patent portfolio. The first week of trial on four patents was held the week of March 9, 2020. The Federal Court of Canada closed due to the COVID-19 pandemic on March 16, 2020, and the trial was temporarily stayed. The trial resumed on May 25, 2020, conducted remotely by video, and concluded on June 17, 2020. The parties filed their written closing submissions on September 30, 2020. The closing arguments were held in January 2021. On June 10, 2022, the Court issued its decision in the case finding in favor of Videotron and its legacy illico platform. Specifically, the Court found invalid each of the asserted claims of the four patents involved in the case. In Canada, the prevailing party in patent litigation is entitled to reimbursement of certain of its costs and expenses. Accordingly, while the exact reimbursement amount has yet to be determined, we have accrued $2.2 million for estimated expense reimbursement.

 

On May 21, 2021, Rovi filed a patent infringement complaint against Videotron in Toronto, Canada, alleging infringement of four patents (“Videotron 2”). On July 21, 2021, the Federal Court of Canada held a case management conference in Videotron 2, shortly before which Videotron filed a motion to strike various portions of the statement of claim. On October 22, 2021, the Court held a hearing on Videotron’s motion to strike. On March 22, 2022, the Court issued an order on Videotron’s motion to strike, dismissing the motion in its entirety. On April 1, 2022, Videotron filed an appeal of the Court’s order dismissing Videotron’s motion to strike. On June 30, 2022, the Court issued its decision in Videotron's appeal in which it ruled in Rovi's favor and dismissed Videotron's appeal. The Court has not set the trial date.

Bell and Telus Patent Infringement Litigation

On January 19, 2018, TiVo filed a patent infringement complaint against Bell Canada (and four of its affiliates) in Toronto, Canada, alleging infringement of six patents (“Bell 1”). On February 2, 2018, TiVo filed a patent infringement complaint against Telus Corporation (and two of its affiliates) in Toronto, Canada, alleging infringement of the same six patents (“Telus 1”). Bell Canada and Telus Corporation were previously indirectly licensed to some of Rovi’s patents through a prior agreement between Rovi and one of their suppliers. Bell 1and Telus 1 were heard together for purposes of pre-trial and trial proceedings. On August 27, 2019, the Court issued an order bifurcating the liability phase from the damages phase of the cases. There is no set trial date or procedural schedule for the damages phase of the cases. The liability and injunction trial on four patents was held from July 13 through August 6, 2020. The closing arguments were held in January 2021. On June 13, 2022, the Court posted a docket entry stating that it anticipates it will issue the judgement and reasons in Bell 1 and Telus 1 to the parties on a confidential basis by August 31, 2022.

 

49


 

On July 27, 2021, Rovi filed a patent infringement complaint against Bell Canada and four of its affiliates, Telefonaktiebolaget L M Ericsson and Ericsson Canada Inc., and MK Systems USA Inc. and MK Mediatech Canada Inc. (collectively, “Defendants”) in Toronto, Canada, alleging infringement of four patents (“Bell 2”). The Defendants filed a motion to strike various portions of the statement of claim in Bell 2. On October 22, 2021, the Federal Court of Canada held a hearing on Defendants’ motion to strike. On March 22, 2022, the Court issued an order on Defendants’ motion to strike, dismissing-in-part and granting-in-part. On April 1, 2022, the Defendants filed a Notice of Motion to Appeal the Court’s order on Defendants’ motion to strike. On June 30, 2022, the Court issued its decision in Defendants' appeal in which it ruled in Rovi's favor and dismissed Defendants' appeal. The Court has yet to set the trial date.

NVIDIA Patent Infringement Litigation

On May 8, 2019, Invensas Corporation and Tessera Advanced Technologies, Inc. filed a complaint against NVIDIA Corporation (“NVIDIA”) in the United States District Court for the District of Delaware, alleging infringement of five patents, and requesting, among other things, that NVIDIA be ordered to pay compensatory damages in an amount no less than a reasonable royalty. NVIDIA answered the complaint on July 1, 2019 and subsequently moved to transfer the case to the United States District Court for the Northern District of California. The court denied NVIDIA’s motion to transfer on September 17, 2019.

 

In September 2020, the Patent Trial and Appeal Board (“PTAB”) instituted IPRs of several patents-in-suit. The parties stipulated to an order staying the litigation pending resolution of the IPR proceedings, and to dismissal of claims relating to two patents. As a result, there are three patents-in-suit remaining. One patent has no IPRs pending against it. Two patents are subject to IPRs. On June 9, 2021, the PTAB held oral arguments in the IPRs. On September 1, 2021, the PTAB issued final written decisions in the IPRs in which it found all challenged claims of the two patents invalid. On November 1, 2021, Invensas filed appeals of each of the IPR decisions with the United States Court of Appeals for the Federal Circuit. Invensas filed its opening brief on March 14, 2022. On June 8, 2022, NVIDIA filed its response brief. On July 22, 2022, Invensas filed its reply brief. No date has been set yet for oral argument. The District Court Litigation will remain stayed pending the outcome of the IPR appeals.

Item 1A. Risk Factors

There were no material changes to the risk factors previously disclosed in Part 1, Item 1A. of our Annual Report on Form 10-K for the year ended December 31, 2021, and Part II, Item A of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, which are incorporated by reference herein.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

50


 

Item 6. Exhibits

 

Exhibit

Number

 

Exhibit Title

 

 

 

10.1

 

Plan Amendment to the Registrant's 2020 Equity Incentive Plan, dated as of April 29, 2022 (incorporated by reference to Appendix A to the Registrant's definite proxy statement filed on March 16, 2022)

 

 

 

10.2

 

Plan Amendment to the Registrant's 2020 Employee Stock Purchase Plan, dated as of April 29, 2022 (incorporated by reference to Appendix B to the Registrant's definite proxy statement filed on March 16, 2022)

 

 

 

31.1

 

Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

 

 

 

31.2

 

Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

 

 

 

32.1

 

Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101.INS

 

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104

 

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

51


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: August 8, 2022

 

XPERI HOLDING CORPORATION

 

 

By:

 

/s/ Robert Andersen

 

 

Robert Andersen

Chief Financial Officer

 

52


EX-31.1


 

Exhibit 31.1

Certification of the Chief Executive Officer

Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

I, Jon Kirchner, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Xperi Holding Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 8, 2022

 

/s/ Jon Kirchner

 

 

Jon Kirchner

 

 

Chief Executive Officer and President

 


 


EX-31.2


 

Exhibit 31.2

Certification of the Chief Financial Officer

Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

I, Robert Andersen, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Xperi Holding Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 8, 2022

 

/s/ Robert Andersen

 

 

Robert Andersen

 

 

Chief Financial Officer

 


 


EX-32.1


 

Exhibit 32.1

CERTIFICATION PURSUANT TO

RULE 13a-14(b) OF THE SECURITIES EXCHANGE ACT OF 1934

AND 18 U.S.C. SECTION 1350

In connection with the Quarterly Report of Xperi Holding Corporation, a Delaware corporation (the “Company”), on Form 10-Q for the period ended June 30, 2022 as filed with the Securities and Exchange Commission (the “Report”), I, Jon Kirchner, Chief Executive Officer and President, certify, pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Jon Kirchner

Jon Kirchner

Chief Executive Officer and President

August 8, 2022

 

CERTIFICATION PURSUANT TO

RULE 13a-14(b) OF THE SECURITIES EXCHANGE ACT OF 1934

AND 18 U.S.C. SECTION 1350

In connection with the Quarterly Report of Xperi Holding Corporation, a Delaware corporation (the “Company”), on Form 10-Q for the period ended June 30, 2022 as filed with the Securities and Exchange Commission (the “Report”), I, Robert Andersen, Chief Financial Officer of the Company, certify, pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Robert Andersen

Robert Andersen

Chief Financial Officer

August 8, 2022

 

A signed original of this written statement required by Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.